Disease
MONDO:0000001A disease is a disposition to undergo pathological processes that exists in an organism because of one or more disorders in that organism.
Also known as: condition, disease, disease or disorder, disease or disorder, non-neoplastic, diseases, diseases and disorders, disorder, disorders
105815 clinical trials for this condition and its sub-types, 735 tagged with Disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Disease
-
Human disease 15 trials · 105,739 incl. sub-types
4 sub-types
- Disease by body system or component 0 trials · 93,739 incl. sub-types Sub-types →
- Disease by etiologic mechanism 0 trials · 59,996 incl. sub-types Sub-types →
- Disease by developmental or physiological process 0 trials · 36,161 incl. sub-types Sub-types →
- Acute disease 22 trials · 4,745 incl. sub-types Sub-types →
-
Non-human animal disease 0 trials · 48 incl. sub-types
55 sub-types
- Integumentary system disorder, non-human animal 0 trials · 15 incl. sub-types Sub-types →
- Hereditary disease, non-human animal 0 trials · 9 incl. sub-types Sub-types →
- Metabolic disease, non-human animal 0 trials · 9 incl. sub-types Sub-types →
- Sheep disease 0 trials · 9 incl. sub-types Sub-types →
- Infectious disease, non-human animal 0 trials · 7 incl. sub-types Sub-types →
- Cattle disease 0 trials · 6 incl. sub-types Sub-types →
- Nervous system disorder, non-human animal 0 trials · 6 incl. sub-types Sub-types →
- Inflammatory disease, non-human animal 0 trials · 5 incl. sub-types Sub-types →
- Nutritional disorder, non-human animal 0 trials · 5 incl. sub-types Sub-types →
- Digestive system disorder, non-human animal 0 trials · 4 incl. sub-types Sub-types →
- Goat disease 0 trials · 4 incl. sub-types Sub-types →
- Cancer or benign tumor, non-human animal 0 trials · 3 incl. sub-types Sub-types →
- Disorder of visual system, non-human animal 0 trials · 3 incl. sub-types Sub-types →
- Endocrine system disorder, non-human animal 0 trials · 3 incl. sub-types Sub-types →
- Swine disease 0 trials · 3 incl. sub-types Sub-types →
- Disorder of orbital region, non-human animal 0 trials · 2 incl. sub-types Sub-types →
- Dog disease 0 trials · 2 incl. sub-types Sub-types →
- Auditory system disorder, non-human animal 0 trials · 1 incl. sub-types Sub-types →
- Fish disease 0 trials · 1 incl. sub-types Sub-types →
- Musculoskeletal system disorder, non-human animal 0 trials · 1 incl. sub-types Sub-types →
- Non-human primate disease 0 trials · 1 incl. sub-types Sub-types →
- Acute disease, non-human animal 0 trials Sub-types →
- Bird disease 0 trials Sub-types →
- Cardiovascular disorder, non-human animal 0 trials Sub-types →
- Cat disease 0 trials Sub-types →
- Chromosomal disorder, non-human animal 0 trials Sub-types →
- Connective tissue disorder, non-human animal 0 trials Sub-types →
- Disease related to transplantation, non-human animal 0 trials
- Disorder of development or morphogenesis, non-human animal 0 trials Sub-types →
- Disorder of glycosylation, non-human animal 0 trials Sub-types →
- Hematologic disorder, non-human animal 0 trials Sub-types →
- Horse disease 0 trials Sub-types →
- Iatrogenic disease, non-human animal 0 trials Sub-types →
- Idiopathic disease, non-human animal 0 trials Sub-types →
- Immune system disorder, non-human animal 0 trials Sub-types →
- Lameness, non-human animal 0 trials
- Mammary gland disorder, non-human animal 0 trials Sub-types →
- Mitochondrial disease, non-human animal 0 trials Sub-types →
- Mouth disorder, non-human animal 0 trials Sub-types →
- Narcolepsy, non-human animal 0 trials Sub-types →
- Obstetric disorder, non-human animal 0 trials Sub-types →
- Occupational disorder, non-human animal 0 trials
- Otorhinolaryngologic disease, non-human animal 0 trials Sub-types →
- Perinatal disease, non-human animal 0 trials
- Poisoning, non-human animal 0 trials
- Post-infectious disorder, non-human animal 0 trials Sub-types →
- Premature aging syndrome, non-human animal 0 trials Sub-types →
- Psychiatric disorder, non-human animal 0 trials Sub-types →
- Radiation-induced disorder, non-human animal 0 trials
- Reproductive system disorder, non-human animal 0 trials Sub-types →
- Respiratory system disorder, non-human animal 0 trials Sub-types →
- Rodent disease 0 trials Sub-types →
- Syndromic disease, non-human animal 0 trials Sub-types →
- Ulcer disease, non-human animal 0 trials Sub-types →
- Urinary system disorder, non-human animal 0 trials Sub-types →
Most studied deeper sub-types
Showing the 400 most recently updated of 15544 trials in this tab.
-
Experimental therapy aims to turn brain tumors against themselves
Cure Not yet recruitingResearchers are testing an experimental therapy called SRN-101 in adults with recurrent high-grade glioma, an aggressive brain cancer that has returned after standard treatment. Participants receive SRN-101 directly into the tumor before planned surgery to remove it. The trial's …
Phase 1 • Sponsor: Nicholas Butowski • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
One small incision vs several: robotic stomach cancer surgery put to the test
Cure Not yet recruitingResearchers are comparing two ways of performing robotic surgery to remove stomach cancer: a single-port approach and a standard multi-port approach. The trial enrolls 212 adults with stomach cancer that can be removed with distal gastrectomy. The main question is whether the sin…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
Can immunotherapy before surgery stop early oral cancer from returning?
Cure Not yet recruitingThis phase 3 trial tests whether adding sintilimab, an immunotherapy drug, to chemotherapy before surgery helps people with early-stage oral squamous cell carcinoma. Participants are adults aged 18 to 75 with cT2N0M0 oral cancer that can be removed by surgery. Half receive sintil…
Phase 3 • Sponsor: caohaotian • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
Can feeding allergens to toddlers build lasting food allergy tolerance?
Cure Not yet recruitingResearchers test whether daily oral immunotherapy can safely treat food allergy in children aged 0 to 2 with peanut, tree nut, or sesame allergy. Half the children receive the therapy, starting with tiny amounts of the allergen and building up over about six months, then a year o…
Sponsor: Copenhagen Studies on Asthma in Childhood • Aim: Cure
Last updated Sep 19, 2026 00:00 UTC
-
Boomerang cartilage graft aims to patch stubborn eardrum holes
Cure Not yet recruitingResearchers test a surgical technique that uses a boomerang-shaped piece of the patient's own cartilage and tissue to repair hard-to-close eardrum perforations. The study includes 50 adults with anterior or subtotal perforations that have been dry for at least three months. Surge…
Sponsor: Assiut University • Aim: Cure
Last updated Sep 19, 2026 00:00 UTC
-
Can a pill rebuild the Brain's insulation? MS trial puts remyelination to the test
Cure Not yet recruitingResearchers are testing an experimental oral drug called PRO-1562 in healthy adults and in adults with relapsing multiple sclerosis who also have long-term vision damage from chronic optic neuropathy. The trial has two parts: a phase 1 safety and absorption study in healthy volun…
Phase 1/2 • Sponsor: Progentos Therapeutics • Aim: Cure
Last updated Sep 19, 2026 00:00 UTC
-
Aortic graft used to rebuild windpipe in thyroid cancer surgery
Cure Not yet recruitingResearchers test a new surgical approach for thyroid cancer that has invaded the windpipe. They replace the affected section with a preserved aortic graft supported by a silicone stent. The goal is to remove all cancer and improve survival. The trial includes patients whose cance…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Could a vaccine shield HIV-Exposed newborns? early trial launches
Vaccine Not yet recruitingThis early-stage trial will test a new HIV vaccine in 22 infants who were exposed to HIV during birth but are not infected. The vaccine is designed to train the immune system to recognize and fight HIV. The main goal is to see if the vaccine is safe and whether it triggers an imm…
Phase 1 • Sponsor: HIV Vaccine Trials Network • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
Nasal spray vaccine aims to stop COVID-19 at the source
Vaccine Not yet recruitingThis study tests a new type of COVID-19 booster vaccine given as a nasal spray. The vaccine uses a weakened live virus to train the immune system, potentially offering stronger protection in the nose and throat where the virus enters. Researchers are enrolling 80 healthy adults a…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
Could a vaccine clear up severe teen acne?
Vaccine Not yet recruitingThis trial is testing whether an experimental mRNA vaccine can safely reduce moderate-to-severe acne in adolescents aged 12 to 17. Participants receive either the vaccine at different dose levels or a placebo, and researchers monitor safety and changes in facial acne lesions. The…
Phase 2 • Sponsor: Sanofi • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
New mRNA vaccine aims to outsmart flu by targeting its hidden parts
Vaccine Not yet recruitingThis Phase 1 trial tests experimental mRNA vaccines designed to protect against many types of influenza A by targeting a stable part of the virus. Healthy adults aged 18 to 59 receive one or two doses of the vaccine candidates, alone or in combination. The study checks for side e…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 20, 2026 00:00 UTC
-
New Self-Amplifying mRNA vaccine aims to better protect transplant patients against COVID-19
Vaccine Not yet recruitingThis study tests a new COVID-19 vaccine (LUNAR-COV19) in 56 adults who received a blood stem cell transplant within the past year. These patients often have weaker immune responses to standard vaccines. The new vaccine uses a self-amplifying mRNA that may produce a stronger and l…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Vaccine
Last updated Sep 19, 2026 00:00 UTC
-
Triple attack on pancreatic tumors: can radiation and immunotherapy make inoperable cancer operable?
Disease control Not yet recruitingResearchers test whether a short course of targeted radiation followed by the immunotherapy drug adebrelimab and NALIRIFOX chemotherapy can shrink locally advanced pancreatic cancer enough to allow surgery. The trial enrolls 36 adults with previously untreated pancreatic ductal a…
Phase 2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Personalized stem cell transplant aims to beat inherited blood cancers
Disease control Not yet recruitingThis study tests whether adjusting chemotherapy doses for each patient can improve outcomes after a stem cell transplant for blood cancers caused by a RUNX1 gene mutation. Up to 98 people aged 4 to 70 with these cancers will receive a transplant from a half-matched donor. The goa…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a checklist and heart monitor stop repeat strokes?
Disease control Not yet recruitingResearchers are testing whether an educational and implementation tool helps hospitals follow best-practice guidelines for preventing second strokes caused by heart conditions. The trial enrolls about 2,400 patients who have had an ischemic stroke or a transient ischemic attack. …
Sponsor: Luciano A. Sposato • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Sparing the liver: targeted chemoembolization meets lenvatinib in liver cancer
Disease control Not yet recruitingResearchers are testing whether a liver-sparing form of chemoembolization, called partial TACE, can boost the anti-tumor effects of the drug lenvatinib in people with liver cancer that cannot be removed by surgery. The trial enrolls about 40 adults with hepatocellular carcinoma w…
Phase 2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Under-the-Skin MS drug: can a shot replace an IV drip?
Disease control Not yet recruitingResearchers are observing how satisfied people with relapsing-remitting multiple sclerosis are when they receive ocrelizumab as an injection under the skin instead of an intravenous infusion. The study follows about 1,800 participants across multiple countries for 12 months, incl…
Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Radioactive missile aims at stubborn kidney tumors
Disease control Not yet recruitingResearchers are testing a radiopharmaceutical called 161Tb-PSMA-1 in adults with metastatic clear cell renal cell carcinoma that has worsened after at least two prior treatments, including immunotherapy and drugs that block blood vessel growth. The trial has two parts: a dose-esc…
Phase 1 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Radioactive drug targets Hard-to-Treat thyroid cancer
Disease control Not yet recruitingThis study tests a radioactive drug called 177Lu-DOTA-EB-TATE in 18 adults with a rare thyroid cancer (Hurthle cell) that has spread and not responded to standard radioactive iodine treatment. The drug is designed to seek out and attach to cancer cells. Participants will receive …
Phase 1/2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a catheter slice thick heart muscle without open surgery?
Disease control Not yet recruitingThis study tests a minimally invasive procedure called SESAME for people with thickened heart muscle that blocks blood flow from the heart. The procedure uses a catheter to make a controlled slice in the muscle, aiming to relieve symptoms like shortness of breath. Researchers wil…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New diabetes pill rybelsus under Real-World safety check in korea
Disease control Not yet recruitingThis study looks at the safety and effectiveness of Rybelsus, a pill for type 2 diabetes, in everyday medical practice in Korea. About 600 adults will take the medicine as their doctor prescribes, and researchers will track side effects and blood sugar control for 26 weeks. The g…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can an experimental pill help teenagers with vitiligo?
Disease control Not yet recruitingResearchers are testing an experimental oral drug called VC005 in teenagers aged 12 to 17 who have non-segmental vitiligo, a condition where patches of skin lose their color. The study measures how the drug moves through the body and checks for safety over up to 24 weeks of treat…
Phase 1/2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can colorectal surgery patients go home in two days?
Disease control Not yet recruitingResearchers are studying whether patients can safely leave the hospital within 48 hours after minimally invasive colorectal surgery. The trial follows 97 adults having elective laparoscopic or robotic surgery for benign or malignant disease. It checks how many meet predefined cli…
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Two-Drug combo targets stubborn KRAS lung cancer
Disease control Not yet recruitingResearchers are testing whether combining BL-B01D1, an experimental antibody-drug conjugate, with glecirasib, a targeted KRAS G12C inhibitor, can shrink tumors in adults with locally advanced or metastatic non-small cell lung cancer that carries a KRAS G12C mutation. The phase 2 …
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can text messages fight anemia? new trial tests digital nutrition for teens
Disease control Not yet recruitingThis study tests whether adding digital nutrition education—via SMS or group sessions—to daily micronutrient supplements can lower anemia rates in 1,200 adolescents aged 15-19 in Dar es Salaam, Tanzania. All participants get supplements and basic nutrition info; some also receive…
Sponsor: Harvard School of Public Health (HSPH) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can an experimental infusion slow muscle loss in FSHD?
Disease control Not yet recruitingThis trial tests an experimental drug called SFL-0821 in adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes progressive muscle weakness. Researchers give the drug by intravenous infusion, either once or multiple times, and compare it agains…
Phase 1/2 • Sponsor: Soufflé Therapeutics, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a daily eye gel replace injections for wet AMD?
Disease control Not yet recruitingThis trial is testing an experimental eye gel called BETA-TT8 for people with wet age-related macular degeneration (AMD), a condition that causes rapid vision loss. The gel is applied to the eye up to three times daily for 12 weeks, and standard injections remain available if nee…
Phase 1/2 • Sponsor: Filamon LTD • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Gene therapy shots aim to save legs from amputation in diabetes
Disease control Not yet recruitingResearchers are testing whether seltoplasmid, a gene therapy injected into the calf muscle, can improve outcomes for people with type 2 diabetes who have poor blood flow to the foot and a non-healing ulcer. All participants first undergo a standard procedure to restore blood flow…
Phase 4 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a weekly injection melt fat hiding in the pancreas?
Disease control Not yet recruitingThis trial tests whether mazdutide, an experimental weekly injection, can reduce fat buildup in the pancreas of adults with overweight or obesity. About 194 participants will receive either mazdutide or a placebo, alongside standard lifestyle advice, for 48 weeks. Researchers wil…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Triple-Drug combo aims to deepen myeloma response before transplant
Disease control Not yet recruitingResearchers are testing whether adding an experimental drug called F182112 to isatuximab and lenalidomide is safe and can help people with newly diagnosed multiple myeloma who are eligible for a stem cell transplant. The trial enrolls about 10 adults aged 18 to 70. Participants r…
Phase 2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can rituximab infusions keep scleroderma lungs stable?
Disease control Not yet recruitingResearchers test whether rituximab helps maintain lung function in adults with systemic sclerosis and interstitial lung disease whose disease has stabilized after initial rituximab treatment. Participants receive rituximab or placebo infusions at months 0, 6, and 12. The main mea…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a liposomal drug combo improve AML treatment for older adults?
Disease control Not yet recruitingResearchers are testing a three-drug regimen called VAM for older or unfit adults with newly diagnosed acute myeloid leukemia (AML). The regimen combines liposomal mitoxantrone, azacitidine, and venetoclax. The trial aims to find the safest and most tolerable dose of liposomal mi…
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can an injected biologic cut steroid Flare-Ups in a Tough-to-Treat asthma complication?
Disease control Not yet recruitingResearchers are studying depemokimab, an injected biologic drug, in adults aged 18 to 75 who have allergic bronchopulmonary aspergillosis (ABPA) along with severe eosinophilic asthma. The study tracks how many asthma attacks need systemic steroids and whether participants' qualit…
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a new drug shrink Hard-to-Treat adrenal tumors?
Disease control Not yet recruitingThis phase 2 trial is testing whether the drug ivonescimab can help control advanced or metastatic adrenal cancers, specifically adrenocortical carcinoma (ACC) and pheochromocytoma/paraganglioma (PPGL), that have not responded to prior treatment. About 20 adults with these rare c…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat scleroderma in landmark trial
Disease control Not yet recruitingThis study tests whether a one-time infusion of specially engineered immune cells (CAR T cells) can improve lung function and skin hardening better than current treatments for people with active systemic sclerosis, a rare autoimmune disease. About 92 adults with lung involvement …
Phase 3 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Engineered yeast pill takes on superbug c. diff in first human trial
Disease control Not yet recruitingThis early-stage trial tests an oral capsule containing a genetically modified probiotic yeast designed to neutralize toxins produced by C. diff bacteria. The study first evaluates safety in healthy adults, then in people at risk for recurrent C. diff infection. Participants take…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Triple-Drug cocktail aims to reverse early heart disease
Disease control Not yet recruitingThis Phase 3 trial will test whether a combination of three cholesterol-lowering drugs—bempedoic acid, ezetimibe, and a high-intensity statin—can reduce and stabilize plaque buildup in the coronary arteries. The study enrolls 103 adults with coronary atherosclerosis who have neve…
Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can tighter blood pressure control in pregnancy prevent serious complications?
Disease control Not yet recruitingThis trial tests whether treating high blood pressure in pregnancy to a stricter target (below 140/90) is better than the usual approach (below 160/110) for women with gestational hypertension or preeclampsia without severe features. About 4,120 pregnant women will be randomly as…
Phase 3 • Sponsor: The George Washington University Biostatistics Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a weekly shot help people who still struggle with weight after bariatric surgery?
Disease control Not yet recruitingMany people who have bariatric surgery do not lose as much weight as expected or regain it over time. This trial tests whether tirzepatide, a weekly injection that acts on two gut hormones, helps adults with obesity lose more weight after surgery. Participants receive either tirz…
Phase 3 • Sponsor: Universidade do Porto • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Could a supplement and drug combo help treat obesity?
Disease control Not yet recruitingThis Phase 2 trial tests whether combining the supplement alpha-lipoic acid with the drug mirabegron can improve how the body processes sugar in people with obesity. Sixty adults aged 18 to 65 with a BMI between 30 and 45 will take the combination or a placebo for 4 weeks. The st…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Smartphone app may boost parenting skills for child outbursts
Disease control Not yet recruitingThis trial tests whether a smartphone app can enhance parent management training (PMT) for children aged 8 to 13 with disruptive behavior disorders, such as conduct disorder or ADHD. Parents receive 12 weekly PMT sessions, and half also use a digital tool with videos, a resource …
Sponsor: National Institute of Mental Health (NIMH) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a vaccine plus a Blood-Vessel blocker stop airway growths from coming back?
Disease control Not yet recruitingThis phase II trial tests whether combining bevacizumab, a drug that limits blood vessel growth, with PRGN-2012, a vaccine-based therapy, can help adults with recurrent respiratory papillomatosis (RRP) avoid needing more surgeries. RRP causes wart-like growths in the airway that …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Engineered immune cells take aim at stubborn solid tumors
Disease control Not yet recruitingThis trial tests a new approach for people with solid tumors that have returned or not responded to standard treatments. The therapy uses the patient's own myeloid cells, a type of immune cell, which are genetically modified in a lab to produce a cancer-fighting protein called IL…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can simple tummy time reshape a Preemie's head?
Disease control Not yet recruitingThis trial tests whether a daily routine of tummy time and careful positioning can help correct cranial asymmetry—a flattened head shape—in premature newborns. About 300 babies born before 37 weeks who are in the neonatal ICU or intermediate care unit will be split into two group…
Sponsor: Hospital de Clinicas de Porto Alegre • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Lab-Grown tumor organoids could pick the right bladder chemo
Disease control Not yet recruitingResearchers are testing whether drug testing in patient-derived organoids can guide chemotherapy for low-grade non-muscle invasive bladder cancer. Adults with primary or recurrent low-grade bladder cancer receive one of four chemo drugs, epirubicin, mitomycin C, gemcitabine, or d…
Phase 2 • Sponsor: Hospital Centre Biel/Bienne • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill-chemo combo takes on hard-to-treat cancers
Disease control Not yet recruitingThis study tests a new drug called SX-682 (a tablet) combined with the chemotherapy docetaxel in people whose head/neck, salivary gland, or prostate cancer has spread or returned after treatment. The goal is to find the right dose and see if the combination shrinks tumors. About …
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a new pill outsmart Drug-Resistant leukemia?
Disease control Not yet recruitingThis phase 2 trial tests an oral drug called nemtabrutinib in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whose cancer has stopped responding to other targeted therapies. Participants take nemtabrutinib once daily in 28-day cycles until the …
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Liver tumors targeted directly: old pump, new drug
Disease control Not yet recruitingThis trial tests whether a drug called carfilzomib, given directly to the liver through an implanted pump, is safe for people whose colon, adrenal, or bile duct cancer has spread to the liver and persists after prior pump therapy. Participants receive weekly infusions of the drug…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a simple checklist help surgeons remove every last cancer cell?
Disease control Not yet recruitingResearchers are testing whether a shared checklist used during lung cancer surgery helps surgeons achieve cleaner, more complete tumor removal. The trial enrolls adults with early-stage non-small cell lung cancer who are scheduled for surgery. Half the participating hospitals use…
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
No more finger pricks? new study tests wearable sensor for pregnancy diabetes
Disease control Not yet recruitingThis study tests whether a continuous glucose monitor (CGM) is better than standard finger-prick tests for managing blood sugar in 100 pregnant women with gestational diabetes. Participants will either wear a small sensor or continue finger-pricking. The goal is to see if CGM is …
Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a single infusion tame tough lupus?
Disease control Not yet recruitingThis early-stage trial is testing an experimental drug called SNC116 in people with refractory systemic lupus erythematosus (SLE), a form of lupus that hasn't improved with standard treatments. The study aims to see if a single intravenous infusion of SNC116 is safe and tolerable…
Early phase 1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a Patient's own airway stem cells repair damaged lungs in COPD?
Disease control Not yet recruitingResearchers are testing REGEND001, a therapy made from a patient's own airway basal stem cells, to see if it can improve lung function in people with chronic obstructive pulmonary disease (COPD) and emphysema. The trial enrolls adults aged 40 to 75 with moderate to severe COPD. P…
Phase 3 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Alpelisib's Long-Term safety tracked in PIK3CA patients
Disease control Not yet recruitingThis study provides continued access to alpelisib for people who are already benefiting from it in a previous Novartis trial. It focuses on tracking long-term safety, including any side effects, in participants with PIK3CA-related overgrowth spectrum or certain breast cancers. Pa…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New chemo cocktail targets pancreatic cancer at every stage
Disease control Not yet recruitingResearchers are testing a chemotherapy combination built around albumin-bound paclitaxel (II) for people with pancreatic cancer. The study has three groups: one for advanced cancer that cannot be removed by surgery, one for cancer that may be removable and receives treatment befo…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a scalp gel turn back male pattern baldness?
Disease control Not yet recruitingResearchers are testing an experimental topical gel called PP405 in men with androgenetic alopecia, the most common form of male pattern hair loss. The trial enrolls about 600 men aged 18 to 55 with moderate hair loss at the top of the scalp. Participants apply either the PP405 g…
Phase 2/3 • Sponsor: Pelage Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a new drug shorten Guillain-Barré recovery?
Disease control Not yet recruitingThis trial tests whether efgartigimod, a drug that lowers harmful antibody levels, can improve recovery in people with Guillain-Barré syndrome (GBS), a rare nerve condition that can cause weakness and paralysis. Adults aged 18 to 70 with recent GBS onset will receive either efgar…
Phase 2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can probiotics make h. pylori antibiotics easier on the gut?
Disease control Not yet recruitingResearchers test whether Bacillus probiotics, given alongside standard four-drug antibiotics for H. pylori infection, reduce gut side effects and improve treatment tolerance. The trial enrolls 336 adults with H. pylori who receive either a single-strain probiotic, a multi-strain …
Sponsor: Anabio R&D • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
First human test of BI 4060107 aims to find safe dose for Hard-to-Treat tumors
Disease control Not yet recruitingResearchers are testing a new biological therapy called BI 4060107 in adults with advanced solid tumors that cannot be removed by surgery. The trial is for people who have tried all available treatments and have no other options. The main goal is to find the highest dose that peo…
Phase 1 • Sponsor: AIMEDBIO • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Engineered immune cells take aim at deadly lung cancer
Disease control Not yet recruitingThis early-phase trial tests a new therapy for people with advanced small cell lung cancer or similar neuroendocrine cancers that have not responded to prior treatment. The approach involves collecting a patient's own immune cells, modifying them in a lab to recognize a protein c…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Bacteria-Based immunotherapy targets pancreatic tumors in first human test
Disease control Not yet recruitingResearchers are testing a new immunotherapy called Lm-LLO-TT in adults with advanced pancreatic ductal adenocarcinoma that has already been treated with chemotherapy. Lm-LLO-TT uses a weakened form of Listeria bacteria engineered to carry a tetanus toxoid antigen, aiming to spark…
Phase 1 • Sponsor: Loki Therapeutics, Inc. • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Laser light may help heal the brain after injury
Disease control Not yet recruitingThis early study tests a new, noninvasive laser treatment called Nano-Pulsed Laser Therapy (NPLT) for people with moderate to severe traumatic brain injury (TBI). The goal is to see if the treatment is safe and can be given soon after injury. Researchers will also check if the la…
Phase 1 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Old antiparasitic drug joins chemo in pancreatic cancer fight
Disease control Not yet recruitingResearchers at the University of Oklahoma are testing whether adding pentamidine, an antiparasitic drug, to standard modified FOLFIRINOX chemotherapy is safe and helps shrink tumors in people with advanced or metastatic pancreatic cancer. Up to 30 adults with confirmed locally ad…
Phase 1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
A pill instead of surgery? trial tests vepugratinib against Low-Grade bladder cancer
Disease control Not yet recruitingResearchers are testing whether an oral drug called vepugratinib can clear low-grade, intermediate-risk bladder cancer that has not invaded muscle, or low-grade upper tract urothelial cancer. The trial enrolls adults whose tumors carry a specific change in the FGFR3 gene. Partici…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New vaccine combo aims to halt prostate cancer growth without surgery
Disease control Not yet recruitingThis phase 2 trial tests a combination of a vaccine (TriAdeno) and an immune-boosting drug (N-803) in 52 men with early-stage, low- or medium-risk prostate cancer who are currently on active surveillance. The vaccine targets three proteins found in prostate cancer cells, while N-…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Zapping resistant tumors: could radiation extend the life of current breast cancer therapy?
Disease control Not yet recruitingThis trial is for people with ER-positive, HER2-negative advanced breast cancer whose disease has started to grow in a few spots while on hormone therapy and a CDK4/6 inhibitor. It tests whether adding targeted radiation (SABR) to those spots allows patients to stay on their curr…
Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Dual immunotherapy plus chemo before surgery: a new way to shrink stomach tumors?
Disease control Not yet recruitingResearchers are testing whether combining an experimental dual immunotherapy drug called QL1706 with standard chemotherapy (docetaxel, oxaliplatin and S-1) before surgery can help patients with locally advanced gastric or gastroesophageal junction cancer. The study enrolls 34 adu…
Phase 2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Daily pill giredestrant put to the test for sticking with breast cancer treatment
Disease control Not yet recruitingResearchers are studying giredestrant, an experimental daily pill, in people with estrogen receptor-positive, HER2-negative early breast cancer. The trial enrolls about 1,500 participants, including some who switch to giredestrant after other treatments. It tracks how many people…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Which biologic works best first for ulcerative colitis? major trial aims to find out
Disease control Not yet recruitingThis study compares four different sequences of biologic drugs (infliximab, filgotinib, ustekinumab, and vedolizumab) in 240 adults with moderate to severe ulcerative colitis. The goal is to see which order of treatments works best to achieve and maintain remission without steroi…
Phase 4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Daily pill takes aim at a rare brain disease that mimics Parkinson's
Disease control Not yet recruitingResearchers are testing an experimental oral drug called ONO-2808 in adults with the Parkinsonian subtype of multiple system atrophy (MSA-P), a rare and progressive brain disorder. The phase 3 trial enrolls about 486 people in the early stages of the disease, within five years of…
Phase 3 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Oral drug VT3989 takes on chemo in mesothelioma survival test
Disease control Not yet recruitingResearchers are comparing an experimental oral drug called VT3989 with standard chemotherapy drugs gemcitabine or vinorelbine in adults with advanced epithelioid pleural mesothelioma. All participants have already received platinum-based chemotherapy and immunotherapy, and their …
Phase 3 • Sponsor: Vivace Therapeutics, Inc • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new care pathway speed up advanced heart failure decisions?
Disease control Not yet recruitingResearchers are testing whether a standardized care pathway helps adults with advanced heart failure in Latin America complete a multidisciplinary evaluation and receive a documented treatment decision within 90 days. The trial includes 360 adults with acquired or structural hear…
Sponsor: CardioVision International Tech, S.A.S. de C.V. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Gene therapy joins forces with chemo and immunotherapy to fight bladder cancer
Disease control Not yet recruitingThis phase 2 trial tests whether adding a gene therapy called nadofaragene firadenovec to standard chemotherapy and immunotherapy can improve outcomes for people with muscle invasive bladder cancer before they have their bladder removed. The gene therapy is placed directly into t…
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can zapping liver and lung tumors boost treatment for nasopharyngeal cancer?
Disease control Not yet recruitingResearchers are testing whether adding CT-guided thermal ablation of liver or lung metastases to standard systemic therapy improves tumor response in people with nasopharyngeal carcinoma. The trial enrolls 138 adults whose primary tumor was cured but who later developed up to fiv…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a shock drug help ARDS patients breathe easier?
Disease control Not yet recruitingThis study tests an experimental drug called centhaquine in 80 adults with moderate to severe ARDS, a life-threatening lung condition. The drug is added to standard care to see if it improves oxygen levels and reduces deaths. Participants must be in the ICU and start treatment wi…
Phase 2 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Experimental drug telaglenastat aims to lower lung blood pressure
Disease control Not yet recruitingThis study tests whether the drug telaglenastat, taken twice daily for 12 weeks, can safely lower blood pressure in the lungs and improve heart and lung function in adults with pulmonary hypertension. About 28 participants will receive the drug on top of their usual care. The mai…
Phase 1/2 • Sponsor: Chan, Stephen, MD, PhD • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can antibiotics dripped through the skull bone reach the brain better than IV drugs alone?
Disease control Not yet recruitingResearchers are testing a new way to deliver antibiotics to the brain in people with moderate to severe bacterial meningitis who are not improving on standard intravenous treatment. The approach combines standard IV antibiotics with a continuous infusion of three antibiotics (van…
Sponsor: yilong Wang • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
First-in-Human biologic JUR-003 put to the test against metastatic prostate cancer
Disease control Not yet recruitingResearchers are running a first-in-human Phase 1 trial of JUR-003, an intravenous biologic, in adults with metastatic prostate cancer. The study has two parts: a dose-escalation phase to find the highest dose people can tolerate, and a dose-expansion phase to look at early anti-t…
Phase 1 • Sponsor: Juri Biosciences, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new antibody boost treatment for Hard-to-Treat HER2 breast cancer?
Disease control Not yet recruitingResearchers are testing whether adding an experimental drug called HLX22 to standard trastuzumab and chemotherapy helps people with locally advanced or metastatic HER2-positive breast cancer that has already been treated with a HER2 ADC. About 90 adults will receive either HLX22 …
Phase 2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two oral drugs join chemotherapy in a bid to shrink pancreatic tumors
Disease control Not yet recruitingResearchers are testing whether adding two oral drugs, avutometinib and defactinib, to standard chemotherapy (mFOLFIRINOX) is safe and can slow or shrink pancreatic ductal adenocarcinoma. The trial has two parts: one for people whose cancer has spread, and one for people whose ca…
Phase 1/2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New injectable drug tested against Hard-to-Treat solid tumors
Disease control Not yet recruitingResearchers are running a Phase I trial of HEC-921, an experimental drug given by intravenous infusion, in adults with advanced malignant solid tumors. The study first gives HEC-921 alone to find the highest dose people can tolerate, then tests it in combination with oxaliplatin,…
Phase 1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Stem cell infusions put to the test against a tough transplant complication
Disease control Not yet recruitingResearchers are testing whether infusions of bone marrow-derived mesenchymal stem cells, called MesenCell, are safe for adults with moderate or severe chronic graft-versus-host disease that has not responded to steroids and other standard treatments. The trial enrolls up to 20 pe…
Phase 1 • Sponsor: Pontifícia Universidade Católica do Paraná • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New 3D heart imaging could sharpen ablation precision
Disease control Not yet recruitingThis study tests a new imaging and guidance system called VERAFEYE that creates a 3D model of the heart to help doctors navigate during catheter ablation for atrial fibrillation. About 50 adults with paroxysmal or persistent atrial fibrillation will have their standard ablation p…
Sponsor: LUMA Vision Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
FitBits and texts: a new way to help moms lower blood pressure after birth
Disease control Not yet recruitingThis study tests a program for new mothers who had high blood pressure during pregnancy. Participants wear a FitBit and receive weekly messages with personalized activity goals. The goal is to see if this approach increases daily steps and improves blood pressure, and whether mom…
Sponsor: Northwestern University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New immunotherapy targets genetic flaw in rare childhood cancers
Disease control Not yet recruitingThis study tests a new immunotherapy designed to help the immune system recognize and attack cancer cells in people with high-risk Ewing sarcoma or desmoplastic small round cell tumor (DSRCT). The treatment targets a specific genetic change found only in these cancer cells, aimin…
Phase 1 • Sponsor: Rabi Hanna • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Device aims to build dialysis access from inside the blood vessels
Disease control Not yet recruitingPeople with end-stage kidney disease need a reliable blood vessel connection, called a fistula, for hemodialysis. This study tests a device called the ePATH System, which creates that connection from inside the blood vessels rather than through open surgery. Researchers will foll…
Sponsor: Pathfinder Medical • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can older women with breast cancer skip chemo? new trial tests CDK4/6 inhibitors
Disease control Not yet recruitingResearchers are testing whether women aged 65 and older with early-stage, lymph node-positive, ER+/HER2- breast cancer can safely skip chemotherapy. Participants receive CDK4/6 inhibitors, with or without endocrine therapy, after surgery. The trial tracks how many women remain fr…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two ways to rebuild a Child's bone: which holds up?
Disease control Not yet recruitingWhen children lose bone to injury, infection, or surgery, doctors can rebuild the limb in different ways. This French study compares two established techniques: the induced membrane method and the vascularized fibula flap, which moves a piece of the calf bone with its blood suppl…
Sponsor: Central Hospital, Nancy, France • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug iptacopan studied for rare kidney disease C3G
Disease control Not yet recruitingThis study looks back at the experiences of 35 adults with a rare kidney disease called C3G who received the drug iptacopan through a special early access program in Spain. Researchers will collect information on patient health, lab results, and how the disease responds to treatm…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Head-to-Head: which JAK inhibitor wins for myelofibrosis patients with low blood counts?
Disease control Not yet recruitingThis study compares two FDA-approved drugs, momelotinib and ruxolitinib, in people with myelofibrosis who also have low blood cell counts. The main goal is to see which drug does a better job at shrinking the spleen and reducing the need for blood transfusions. About 268 particip…
Phase 4 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New injection MWN117 tested for safety in obesity
Disease control Not yet recruitingResearchers are testing an experimental drug called MWN117 to see if it is safe and how the body handles it. The trial enrolls 48 healthy and obese Chinese adults who receive a single injection under the skin of either MWN117 or a placebo. Participants are split into groups that …
Phase 1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a diabetes pill help the heart heal after a hole is closed?
Disease control Not yet recruitingAdults with a secundum atrial septal defect (a hole in the heart) who are scheduled for device closure receive either dapagliflozin or a placebo for six months. Researchers use advanced echocardiography to measure how well the right side of the heart recovers and reverses its enl…
Sponsor: Assiut University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Immune-Boosting drug and vaccine aim to fight returning prostate cancer
Disease control Not yet recruitingThis Phase II trial tests whether an immune-boosting drug (N-803) alone or combined with a vaccine (ETBX-071) can lower PSA levels in men whose prostate cancer has returned after targeted radiation therapy. Participants receive up to eight cycles of treatment and are followed for…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a simple checklist cut unnecessary antibiotics for diverticulitis?
Disease control Not yet recruitingAcute uncomplicated diverticulitis is often treated with antibiotics, but evidence suggests they are not always needed. This study evaluates whether a standardized treatment approach based on clinical findings, lab results, other health conditions, and CT scans can reduce unneces…
Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New injection for obesity tested for safety in first human trial
Disease control Not yet recruitingResearchers are testing an experimental injectable drug called SHR-1179 in obese adults. The trial aims to see how safe and tolerable a single dose is, and how the body processes the drug. About 50 participants with a body mass index between 28 and 35 will receive either SHR-1179…
Phase 1 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a smaller dose of this cancer drug still work? new trial aims to find out
Disease control Not yet recruitingThis phase 2 trial is testing whether a lower dose of the immunotherapy drug nivolumab, given less often, can still control cancer in people with various advanced or metastatic cancers. The goal is to see if a cheaper, more accessible regimen works as well as the standard high-co…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two antifungal pills go head to head against a fungus that scars the lungs
Disease control Not yet recruitingResearchers compare two oral antifungal medicines, itraconazole and posaconazole, in people with chronic pulmonary aspergillosis, a fungal infection that damages the lungs over time. The trial enrolls 220 adults who have not yet received antifungal treatment and assigns them to o…
Phase 3 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Experimental drug put to the test against Hard-to-Treat GI cancers
Disease control Not yet recruitingResearchers are testing an experimental injectable drug called ALK-N001 in adults with advanced gastrointestinal tumors, including esophageal and colorectal cancers that have worsened after standard treatment. The phase II trial gives the drug intravenously every two weeks at one…
Phase 2 • Sponsor: Zhejiang Anglikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a diabetes and Weight-Loss drug help people quit meth?
Disease control Not yet recruitingResearchers at UT Southwestern Medical Center are testing whether tirzepatide, a drug approved for diabetes and weight loss, can help people with moderate to severe methamphetamine use disorder reduce or stop using the drug. The trial enrolls 228 adults aged 18 to 65 who are over…
Phase 2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Protein-Guided missiles: can mass spectrometry match the right drug to the right tumor?
Disease control Not yet recruitingResearchers are testing whether measuring specific proteins in tumors can help match patients with advanced pancreatic or breast cancer to antibody-drug conjugates that are more likely to work for them. The trial enrolls 225 adults whose cancer has progressed after prior treatmen…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can half the Clot-Busting drug save lives with less bleeding?
Disease control Not yet recruitingResearchers are testing whether a lower dose of the clot-dissolving drug alteplase can treat life-threatening pulmonary embolism as effectively as the standard full dose while causing less severe bleeding. The trial enrolls adults with acute high-risk pulmonary embolism, a condit…
Phase 4 • Sponsor: Sahlgrenska University Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Two-Drug combo takes aim at Hard-to-Treat lung cancer
Disease control Not yet recruitingResearchers are testing whether adding the immunotherapy adebrelimab to HS-20093 (risvutatug rezetecan) works better than HS-20093 alone in adults with advanced or metastatic non-squamous non-small cell lung cancer that has already been treated and has no actionable gene changes.…
Phase 2 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can scans predict which liver cancer patients need extra local therapy?
Disease control Not yet recruitingResearchers are studying whether adding local treatments such as ablation, radiotherapy, or transarterial therapy to the drug combination atezolizumab plus bevacizumab helps certain patients with unresectable hepatocellular carcinoma live longer. The study uses medical records an…
Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can some children skip the drain after choledochal cyst surgery?
Disease control Not yet recruitingCholedochal cyst is a congenital bile duct problem that surgeons treat by removing the cyst and rebuilding the bile duct with a Roux-en-Y hepaticojejunostomy, often using a surgical robot. Surgeons usually leave an abdominal drainage tube in place afterward, but better robot prec…
Sponsor: Xueqiang Yan • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a new biologic slow kidney damage in IgA nephropathy?
Disease control Not yet recruitingThis phase 2 trial is investigating whether an experimental drug called ARGX-121 can improve outcomes for adults with IgA nephropathy, a kidney disease that can lead to kidney failure. Participants will receive either ARGX-121 or a placebo, while continuing their usual care. The …
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
One-Time CAR-T infusion tested against progressive MS
Disease control Not yet recruitingResearchers are testing a one-time CAR-T cell therapy called C-CAR168 in adults with progressive multiple sclerosis that has not responded to standard treatments. The therapy uses a patient's own immune cells, engineered to target two proteins, and is given as a single intravenou…
Phase 1/2 • Sponsor: AbelZeta Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Virtual heart team aims to close medication gap for veterans with heart failure
Disease control Not yet recruitingThis study tests whether a virtual team of clinical pharmacists and cardiologists can help doctors prescribe the right heart failure medications for Veterans. Many patients do not receive all recommended drugs at effective doses after a hospital stay. The team reviews patient rec…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
AI city halls: could Robot-Run domes cure addiction and homelessness?
Disease control Not yet recruitingThis study will test whether living in a self-contained, AI-managed community (called a Microcity) can improve mental health and reduce addiction in adults with conditions like autism, ADHD, substance use disorders, and behavioral addictions. Up to 1 million participants will liv…
Sponsor: Veterans Recovery Network Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can coconut oil and moringa rinses fight gum disease in diabetic kids?
Disease control Not yet recruitingResearchers test whether coconut oil pulling or a moringa mouthwash can reduce gingivitis in children with diabetes, compared with chlorhexidine. Thirty children aged 6 to 12 with mild to moderate gingivitis use one of the three rinses. The team measures gum inflammation and leve…
Sponsor: Amira Yehia Zakaria • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New antibody pair takes aim at advanced liver cancer in major trial
Disease control Not yet recruitingResearchers are testing whether a new combination of two antibodies, JS207 and JS007, works better than the standard first-line treatment of toripalimab plus bevacizumab for advanced liver cancer. The trial enrolls about 560 adults with liver cancer that cannot be removed by surg…
Phase 3 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New dialysis fluid may slow hardening of arteries in kidney patients
Disease control Not yet recruitingThis study tests whether a citrate-based dialysis fluid with extra magnesium can slow or prevent blood vessel hardening in adults on long-term hemodialysis. Eighty stable patients will receive either the new fluid or a standard one for 12 months. Researchers will measure blood ma…
Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a drug combo shrink esophageal tumors before surgery?
Disease control Not yet recruitingResearchers are testing whether giving sacituzumab tirumotecan plus toripalimab before surgery helps people with locally advanced esophageal squamous cell carcinoma. Participants receive three cycles of the combination, then undergo standard surgery to remove the tumor. The main …
Phase 2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a new drug combo shrink High-Risk throat tumors?
Disease control Not yet recruitingThis phase II trial tests whether the experimental drug BL-B01D1, given with or without a PD-1 antibody, can improve tumor shrinkage in people with high-risk locally advanced nasopharyngeal carcinoma, a type of throat cancer. Participants also receive standard chemotherapy drugs …
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a breast cancer combo be safer for diabetics?
Disease control Not yet recruitingThis trial is testing whether a combination of drugs—inavolisib plus fulvestrant, with or without palbociclib—is safe for people with a specific type of advanced breast cancer (HR+, HER2-negative) that has a PIK3CA mutation, and who also have type 2 diabetes. The main focus is on…
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a quieter, automated blood pressure check help more people control hypertension?
Disease control Not yet recruitingResearchers are testing whether a standardized automated blood pressure measurement protocol in Australian general practice clinics improves hypertension control among adults. The protocol uses a validated device that takes several readings automatically after a five-minute rest,…
Sponsor: Menzies Institute for Medical Research • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can deep gum pockets heal without a scalpel?
Disease control Not yet recruitingResearchers compare two ways to treat deep defects in the gums of people with advanced periodontitis. One approach cleans the pockets with minimally invasive non-surgical therapy, while the other uses a single flap surgical procedure. The trial measures gum attachment gain and us…
Sponsor: Cairo University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can two drugs spare the bladder in aggressive bladder cancer?
Disease control Not yet recruitingResearchers are testing whether combining enfortumab vedotin and pembrolizumab can shrink muscle-invasive bladder cancer enough to avoid removing the bladder or using radiation. The trial enrolls 25 adults with confirmed muscle-invasive urothelial carcinoma that has not spread. P…
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New device could cut stroke risk in kidney patients on dialysis
Disease control Not yet recruitingThis pilot study tests a procedure called left atrial appendage occlusion (LAAO) using the Watchman Flx PRO device in 40 dialysis patients with atrial fibrillation. The goal is to see if it safely reduces stroke and major bleeding compared to standard care. Participants will be f…
Sponsor: Prince of Wales Hospital, Shatin, Hong Kong • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Apps and wearables join forces to tackle psoriatic arthritis
Disease control Not yet recruitingThis study tests a digital health program designed to support people with psoriatic arthritis in managing their condition. Participants use a mobile app for symptom tracking and lifestyle tips, plus tools for sleep, stress, and physical activity, along with a smartwatch. The goal…
Sponsor: Sociedade Portuguesa de Reumatologia • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Balloon vs stent: which works best for clogged leg arteries?
Disease control Not yet recruitingThis study compares two treatments for when a leg artery stent narrows again (in-stent restenosis). About 578 patients will receive either a drug-coated balloon or a drug-eluting stent, both of which release medication to keep the artery open. The goal is to see which approach re…
Sponsor: Chunshui He • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a second antibody drug help Guillain-Barré patients walk again sooner?
Disease control Not yet recruitingGuillain-Barré syndrome (GBS) is a rare condition where the immune system attacks nerves, causing weakness that can progress to paralysis. Standard treatment is intravenous immunoglobulin (IVIg), but recovery is often slow. This phase 2 trial tests whether adding an experimental …
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug combo takes aim at a Hard-to-Treat lung cancer mutation
Disease control Not yet recruitingResearchers are testing whether adding the experimental oral drug HS-10370 to platinum-based chemotherapy, with or without the immunotherapy adebrelimab, works better than tislelizumab plus chemotherapy. The trial enrolls about 448 adults with previously untreated, locally advanc…
Phase 3 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a Once-Daily pill tame bad cholesterol?
Disease control Not yet recruitingResearchers are testing an oral drug called enlicitide decanoate in adults with hyperlipidemia, a condition marked by high cholesterol. The phase 3 trial enrolls 150 people in India who have had a heart-related event or face high risk, and who still have elevated LDL cholesterol.…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Four pills, one goal: can a new combo tame type 2 diabetes?
Disease control Not yet recruitingResearchers are testing whether a combination of four experimental oral drugs, AD-233A, AD-233B, AD-233C and AD-233D, can improve blood sugar control in adults with type 2 diabetes. The Phase III trial enrolls about 354 participants and compares the drug combination against an ac…
Phase 3 • Sponsor: Addpharma Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New Antibody-Drug conjugate put to the test against Hard-to-Treat cancers
Disease control Not yet recruitingResearchers are running a first-in-human study of MGC030, an antibody-drug conjugate, in people with advanced solid tumors that have come back or stopped responding to standard treatment. The trial includes participants with urothelial, colorectal, gastric, gastroesophageal, esop…
Phase 1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for Hard-to-Treat prostate cancer: experimental drug zanzalitinib under study
Disease control Not yet recruitingThis study tests a new drug called zanzalitinib in people with a type of advanced prostate cancer that no longer responds to hormone therapy and has spread to soft tissues or organs. The goal is to see if the drug can slow or stop cancer growth. About 19 participants will receive…
Phase 2 • Sponsor: Pedro Barata, MD, MSc • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Robot tutor aims to help kids master asthma inhalers
Disease control Not yet recruitingThis trial tests whether a single 10-minute lesson from an artificially intelligent robot can improve inhaler technique and asthma control in children ages 4 to 11. Researchers will compare standard asthma education with the robot-led session, measuring inhaler skills, medication…
Sponsor: University of Miami • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can zapping residual lung cancer spots extend remission?
Disease control Not yet recruitingResearchers are testing whether adding focused radiation to the few remaining cancer spots helps people with advanced EGFR-mutant non-small cell lung cancer live longer without their disease getting worse. Participants first receive a third-generation EGFR-targeted drug plus plat…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug combo could shorten histoplasmosis treatment by half
Disease control Not yet recruitingThis study tests if a single high dose of an antifungal drug works better than the standard daily dose for treating moderate to severe histoplasmosis, a serious lung infection. It also compares a newer oral drug to the standard one, and checks if 6 months of treatment is as good …
Phase 3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a new pill ease muscle weakness in myositis?
Disease control Not yet recruitingThis phase III trial tests whether the oral drug nerandomilast can improve symptoms of idiopathic inflammatory myopathies, a group of rare autoimmune diseases that cause muscle weakness and inflammation. Adults with active myositis are randomly assigned to take nerandomilast or a…
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a liquid diet calm Crohn's in kids?
Disease control Not yet recruitingResearchers at Assiut University Children Hospital are studying whether a specially prepared medical milk formula called Modulen IBD can bring Crohn's disease into remission and keep it there in children and teenagers. About 40 young patients with mild to moderate active Crohn's …
Sponsor: Assiut University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a simple lifestyle quiz lower blood pressure better than standard advice?
Disease control Not yet recruitingThis study tests whether using a 21-question tool to understand a person's daily habits, then giving tailored advice, can lower blood pressure more than routine counseling. Researchers will compare two groups of adults with hypertension over three months. The goal is to see if pe…
Sponsor: Indus Hospital and Health Network • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug RO7830698 put to the test for COPD
Disease control Not yet recruitingResearchers are testing an experimental drug called RO7830698 to see if it is safe and well tolerated. The trial includes healthy volunteers and people with chronic obstructive pulmonary disease (COPD). Participants receive either RO7830698 or a placebo, and researchers track sid…
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Antibody-Drug conjugate takes aim at c-Met-High lung cancer
Disease control Not yet recruitingResearchers are testing whether an experimental drug called telisotuzumab adizutecan works better than standard chemotherapy for people with non-squamous non-small cell lung cancer that has grown after earlier treatment. The trial enrolls about 660 participants whose tumors are E…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can ancient frankincense Out-Clean the Dentist's standard root canal rinse?
Disease control Not yet recruitingResearchers test whether a rinse made from frankincense (Boswellia sacra) removes bacteria from infected root canals as well as the standard sodium hypochlorite rinse. Thirty adults aged 18 to 50 with a dead or infected tooth take part. Each person is randomly assigned to one of …
Early phase 1 • Sponsor: Oman Dental College • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New study aims to cut pneumonia risk in HIV patients with smart medication checks
Disease control Not yet recruitingThis study tests whether a pharmacist-led electronic consultation can improve lung health for people with HIV who smoke or use certain medications that raise pneumonia risk. Pharmacists will review records and suggest changes like smoking cessation aids, vaccines, or stopping unn…
Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
A common antioxidant may help platelets recover faster after stem cell transplant
Disease control Not yet recruitingThis trial tests whether the antioxidant N-acetylcysteine (NAC) can help platelets recover faster after a stem cell transplant in people with severe aplastic anemia. Participants take NAC capsules three times daily from two weeks before transplant until two months after. The stud…
Phase 3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a Chest-Tube enzyme cocktail clear TB lung fluid?
Disease control Not yet recruitingResearchers at a Malaysian hospital reviewed ten years of records for 160 adults who received intrapleural fibrinolytic therapy, a mix of alteplase and DNase delivered through a chest tube, for complicated pleural infection. The study compares how well the treatment cleared fluid…
Sponsor: National University of Malaysia • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a targeted drug delivery system shrink lung tumors?
Disease control Not yet recruitingThis trial tests an experimental drug called TUB-040 in adults with advanced non-small cell lung cancer that cannot be removed with surgery or has spread. TUB-040 is designed to attach to a protein on cancer cells and deliver a toxic payload directly to the tumor, potentially kil…
Phase 2 • Sponsor: Tubulis GmbH • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a work health check catch diabetic eye damage before it steals sight?
Diagnosis Not yet recruitingMany people with diabetes skip regular eye exams, even though early treatment can prevent vision loss. This pilot study tests whether offering retinal photography during routine occupational health visits makes screening easier to access. Workers with diabetes attend one visit wh…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can wireless monitors make ER vitals easier for autistic children?
Diagnosis Not yet recruitingAutistic children in the emergency department often miss full vital sign checks because standard equipment can be distressing. This pilot study randomizes 100 children aged 2 to 17 to have their heart rate, breathing, oxygen and temperature measured either with wireless wearable …
Sponsor: Hamilton Health Sciences Corporation • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
New PET tracer aims to light up hidden cancer targets
Diagnosis Not yet recruitingResearchers are testing a new PET/CT imaging tracer called [68Ga]-LY4257529 that targets a protein called GRPR, which some cancers make in large amounts. The study includes up to 60 adults with breast cancer or other tumors known or suspected to express GRPR, such as prostate, ov…
Early phase 1 • Sponsor: Jewish General Hospital • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Your phone as a stethoscope: can an app spot hidden heart valve disease?
Diagnosis Not yet recruitingResearchers are testing whether a smartphone app called Stethophone can help primary care doctors find moderate or severe aortic stenosis in adults aged 70 and older. The app turns a phone into a digital stethoscope and analyzes heart sounds for murmurs that may signal the condit…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Radioactive tracer aims to light up hidden lung scarring
Diagnosis Not yet recruitingResearchers at Mayo Clinic are testing an investigational radioactive tracer called 68Ga-FAPI-46 to see how it distributes in the lungs of people with interstitial lung disease. About 10 participants with a clinical diagnosis of ILD and lung abnormalities on a recent CT scan rece…
Phase 1 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Blood test could spare Head-Injury patients a brain scan
Diagnosis Not yet recruitingResearchers are testing whether adding a brain-injury blood test to standard clinical guidelines can safely reduce the number of brain CT scans ordered for adults who come to the emergency department with a suspected head injury. The blood test measures two proteins, GFAP and UCH…
Sponsor: University of Michigan • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can a blood test before pancreatic surgery predict a dangerous leak?
Diagnosis Not yet recruitingResearchers are studying whether immune markers in a blood sample taken before pancreatic cancer surgery can predict a serious complication called postoperative pancreatic fistula, where digestive fluids leak from the surgical connection. Adults scheduled for curative-intent panc…
Sponsor: Institut Paoli-Calmettes • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Could a handheld ultrasound help clinics spot heart failure sooner?
Diagnosis Not yet recruitingResearchers at Corewell Health West are testing whether medical assistants can use a handheld ultrasound device to estimate heart pumping function in people with new heart symptoms. The trial enrolls up to 100 adults at rural outpatient clinics who have not had a recent echocardi…
Sponsor: Corewell Health West • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can a special MRI match CT for spotting knee bone damage?
Diagnosis Not yet recruitingResearchers at Assiut University are testing whether a specialized MRI technique called multi-echo fast field echo (mFFE) can detect cortical bone changes in knee osteoarthritis as accurately as CT scans. The study enrolls 80 adults aged 40 and older with suspected or confirmed k…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
Can 'Queen Mothers' bring HIV testing to the doorstep?
Diagnosis Not yet recruitingResearchers are testing whether sex work managers, called queen mothers, can hand out and collect HIV self-tests and self-collected STI test kits at places where female sex workers meet and work in Lusaka. The study compares this peer-supported approach with the current standard …
Sponsor: University of North Carolina, Chapel Hill • Aim: Diagnosis
Last updated Sep 20, 2026 00:00 UTC
-
App aims to catch a hidden radiotherapy side effect
Diagnosis Not yet recruitingRadiation pneumonitis is a lung inflammation that can appear weeks after radiotherapy for lung cancer, and patients may not link their symptoms to the earlier treatment. Researchers developed a smartphone app called PneumoCheck for patients to use at home, hoping it helps detect …
Sponsor: University Hospital Schleswig-Holstein • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Heart attack delay may signal kidney risk after angioplasty
Diagnosis Not yet recruitingResearchers are studying whether the total time from heart attack symptom onset to balloon inflation during angioplasty helps predict contrast-induced nephropathy, a kidney complication that can occur after the procedure. The trial enrolls 400 adults with ST-segment elevation myo…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
A 2.2 mm scope could spot cancerous tissue in minutes, not days
Diagnosis Not yet recruitingDoctors usually send colorectal tissue to a lab and wait days for results. This pilot study tests a miniaturized device called MULTISCOPE that uses light-based imaging to tell healthy tissue from cancerous tissue in real time. Researchers will examine 30 tissue samples removed du…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Mapping the DNA test that decides who gets PARP inhibitors
Diagnosis Not yet recruitingResearchers are reviewing medical records from about 1,125 women in Italy with newly diagnosed advanced high-grade epithelial ovarian cancer. The study focuses on how hospitals test tumors for homologous recombination deficiency (HRD), a DNA repair flaw that can make PARP inhibit…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
AI helps surgeons see brain tumors better during surgery
Diagnosis Not yet recruitingThis trial tests a new AI device that helps surgeons see brain tumors on ultrasound images during surgery. The AI highlights tumor tissue in real time, which may help remove more of the tumor while protecting healthy brain. The study involves 100 adults scheduled for brain tumor …
Phase 3 • Sponsor: Hospital del Rio Hortega • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
New blood test method for liver disease could make diagnosis easier
Diagnosis Not yet recruitingThis study checks if a simpler way to collect blood samples works as well as the standard method for the HepQuant DuO liver test. The test involves drinking a natural substance and taking blood samples 20 and 60 minutes later. Researchers will compare different blood collection t…
Sponsor: HepQuant, LLC • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Breath test aims to classify leukaemia in hours, not days
Diagnosis Not yet recruitingDoctors often wait days for genetic tests to classify acute myeloid leukaemia (AML) and guide treatment. This trial tests whether breath analysis can detect metabolic products from leukaemia and classify the disease faster. Participants give breath samples and extra blood tests d…
Sponsor: Jeremy Deuel • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Virtual jaw simulator could spot hidden joint problems
Diagnosis Not yet recruitingThis study will test a 4D virtual simulator called Modjaw to see if it helps doctors diagnose temporomandibular joint (TMJ) disorders more accurately. About 20 adults with suspected disc displacement will use the device, and the results will be compared to MRI scans. The goal is …
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Could a routine blood test flag a dangerous pregnancy complication?
Diagnosis Not yet recruitingPlacenta accreta spectrum is a serious pregnancy complication where the placenta grows too deeply into the uterus, risking severe bleeding during delivery. Doctors usually rely on ultrasound to detect it, but ultrasound accuracy varies. This study checks whether simple blood test…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Smartphone app aims to catch rheumatoid arthritis before it takes hold
Diagnosis Not yet recruitingResearchers are testing whether a smartphone app called DETECTRA can help doctors diagnose rheumatoid arthritis earlier in adults who have joint symptoms and a positive ACPA blood test. Participants are randomly assigned to receive standard care alone or standard care plus the ap…
Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
AI second pair of eyes could speed up finding hidden bleeding
Diagnosis Not yet recruitingResearchers are testing an AI software tool called DSA-VDet v1.0 that highlights suspected bleeding on angiography images in real time. The trial enrolls adults with suspected acute bleeding in various body regions who need a digital subtraction angiography (DSA) procedure. Docto…
Sponsor: Zhongda Hospital • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can a glowing dye show surgeons where head and neck tumors end?
Diagnosis Not yet recruitingResearchers at Washington University School of Medicine are studying whether a fluorescent dye called indocyanine green can help visualize the edges of head and neck squamous cell carcinoma during surgery. The study plans to enroll 25 adults who are having surgery for confirmed o…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
A soft patch that watches your heart beat in real time
Diagnosis Not yet recruitingResearchers are testing a soft, wearable ultrasound patch that sticks to the chest and continuously images the heart in adults and children with severe heart conditions in intensive care. The study compares heart function measurements from the patch with results from standard bed…
Sponsor: Kunjing Pang • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Could a week of acid drugs double as a GERD test?
Diagnosis Not yet recruitingResearchers are testing whether early symptom relief from tegoprazan can help diagnose gastroesophageal reflux disease (GERD). Adults with frequent heartburn or acid regurgitation take tegoprazan or a placebo once daily for one week. By comparing symptom improvement between the g…
Phase 4 • Sponsor: HK inno.N Corporation • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
DNA test for infections: can it guide antibiotic decisions?
Diagnosis Not yet recruitingResearchers are running a large observational registry to see how a blood test called metagenomic sequencing is used in routine care for people with or at risk of serious infections, including those with weakened immune systems. The study enrolls participants at multiple hospital…
Sponsor: Karius, Inc. • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can software read sleep studies as well as a specialist?
Diagnosis Not yet recruitingResearchers compare automated software with manual scoring by expert sleep specialists for sleep study records from adults with obstructive sleep apnea. The study measures how closely the two methods agree on the apnea-hypopnea index, a key measure of breathing pauses during slee…
Sponsor: Ain Shams University • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
PET scans may reveal which aortic valves will worsen
Diagnosis Not yet recruitingResearchers at Massachusetts General Hospital are studying whether molecular imaging and detailed biological profiling can predict how quickly aortic stenosis gets worse. The trial enrolls 100 adults with mild to moderate calcific aortic stenosis. Participants receive a baseline …
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can a scan before birth predict a Baby's heart defect?
Diagnosis Not yet recruitingResearchers at Assiut University Hospitals are studying how well fetal heart scans before birth match the heart diagnoses babies receive after delivery. The study includes pregnant women referred for fetal echocardiography and newborns with confirmed critical congenital heart dis…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can two blood markers catch sepsis before it turns deadly?
Diagnosis Not yet recruitingSepsis is hard to spot early because its first symptoms look like many other conditions. Researchers at emergency departments in Taiwan are studying whether two blood markers, presepsin and immature granulocytes, can help doctors tell sepsis apart from other causes of inflammatio…
Sponsor: Chang Gung Memorial Hospital • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Magnetic heart signals could help ER doctors spot hidden heart risk
Diagnosis Not yet recruitingResearchers are testing whether a non-invasive device that reads the heart's magnetic signals can help emergency department doctors tell high-risk from low-risk chest pain. The study enrolls adults 22 and older who arrive with symptoms suggesting a possible heart attack and who f…
Sponsor: SB Technology, Inc. • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
AI boosts colonoscopy accuracy in massive new trial
Diagnosis Not yet recruitingThis study tests whether an artificial intelligence (AI) system can help doctors spot more precancerous polyps and colorectal cancers during colonoscopy compared to standard procedures. Over 3,300 adults scheduled for screening or surveillance will be randomly assigned to AI-assi…
Sponsor: Zhejiang University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can a kidney ultrasound scan warn of kidney damage after heart bypass surgery?
Diagnosis Not yet recruitingAcute kidney injury is a common complication after coronary artery bypass grafting. This observational study examines whether two measurements from kidney Doppler ultrasound, the renal augmented velocity index and the renal resistive index, can predict which patients will develop…
Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
A less invasive brain monitor takes on Epilepsy's hardest seizures
Diagnosis Not yet recruitingResearchers are testing whether a minimally invasive electrode placed under the scalp, called subgaleal EEG, can detect seizures as well as the standard approach that places electrodes inside the brain. The study enrolls 15 adults with drug-resistant epilepsy who are already sche…
Early phase 1 • Sponsor: Adraxe Corp. • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can a fetal heart ultrasound index predict trouble in High-Risk pregnancies?
Diagnosis Not yet recruitingResearchers at Assiut University are studying whether two ultrasound measures of fetal heart function and blood flow can predict poor outcomes in pregnancies complicated by diabetes or preeclampsia. The study enrolls 69 pregnant women, including those with gestational diabetes, p…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can a common steroid shield breast cancer patients from a dangerous drug side effect?
Prevention Not yet recruitingTrastuzumab deruxtecan (T-DXd) treats metastatic breast cancer but can cause interstitial lung disease (ILD), a form of lung inflammation that sometimes forces patients to stop treatment. Researchers are testing whether giving dexamethasone before each T-DXd infusion lowers the c…
Phase 3 • Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can a mobile app plus a breast model teach women to fight cancer fatalism?
Prevention Not yet recruitingResearchers test a hybrid breast cancer education program for women aged 20 to 65 who visit an obstetrics and gynecology clinic. The program combines a face-to-face session using a breast model with four weeks of educational messages and reminders sent through a mobile app. The t…
Sponsor: Kahramanmaras Sutcu Imam University • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can a pharmacist chat group help stop HIV?
Prevention Not yet recruitingResearchers at the University of Washington are studying whether an online community of practice helps pharmacists learn to prescribe PrEP, a daily pill that prevents HIV. The study enrolls about 500 pharmacists and pharmacy staff across the United States whose pharmacies do not …
Sponsor: University of Washington • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
One dose to block the flu: baloxavir put to the test in households
Prevention Not yet recruitingResearchers are testing whether a single dose of the antiviral drug baloxavir marboxil can stop influenza from spreading among people who live with someone who has the flu. The trial enrolls households in China where one person has confirmed influenza and up to five other members…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Alzheimer's vaccine aims to clear amyloid before memory fades
Prevention Not yet recruitingResearchers are testing an experimental vaccine called AV-1959R in adults aged 55 to 80 who have amyloid buildup in the brain but no memory or thinking problems. The trial compares the vaccine with a placebo to see whether it is safe, triggers an immune response, and lowers brain…
Phase 2 • Sponsor: Institute for Molecular Medicine • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can text messages and small rewards stop drinking in pregnancy?
Prevention Not yet recruitingResearchers are testing a behavioral program that sends supportive text messages and offers small rewards to pregnant women who test positive for alcohol, tobacco, or cannabis use in South Africa. The program aims to reduce substance use during pregnancy and breastfeeding, which …
Phase 2 • Sponsor: Philadelphia College of Osteopathic Medicine • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Two common drugs put to the test against kidney stones caused by cosmetic paraffin injections
Prevention Not yet recruitingParaffin disease happens when people inject paraffin oil into muscle for cosmetic enlargement, causing chronic inflammation, high blood calcium, kidney stones, and kidney damage. Researchers are testing whether empagliflozin or losartan, two drugs already used for kidney protecti…
Phase 2/3 • Sponsor: Martin Blomberg Jensen • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can a smart bracelet and app stop a second stroke?
Prevention Not yet recruitingResearchers are testing whether a digital program that combines a smart bracelet and a mobile app can help people who have had an ischemic stroke avoid another one. The study enrolls adults who recently had a stroke and also have high blood pressure and diabetes. Half receive usu…
Sponsor: Affiliated Hospital of Nantong University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
How long does RSV protection last in a Baby's nose?
Prevention Not yet recruitingClesrovimab is an FDA-approved antibody shot for infants under 8 months entering their first RSV season when their mothers did not get an RSV vaccine in pregnancy. Researchers at Emory University are measuring antibody levels in the blood and noses of 24 healthy infants who recei…
Phase 4 • Sponsor: Emory University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Could a cancer drug stop a deadly complication in transplant patients?
Prevention Not yet recruitingThis study tests whether the drug rituximab can safely clear Epstein-Barr virus (EBV) from the blood of people who have received a solid organ transplant. High levels of EBV can lead to a serious cancer called post-transplant lymphoproliferative disorder (PTLD). The trial will en…
Phase 1 • Sponsor: Jennifer Amengual • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can an AI chatbot coach people away from type 2 diabetes?
Prevention Not yet recruitingResearchers are testing an AI chatbot that gives personalized, culturally tailored advice on nutrition, physical activity, and goal setting to adults at risk for type 2 diabetes. About 30 adults aged 18 to 55 will use the chatbot for 6 weeks. The study will check whether the chat…
Sponsor: Emory University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
AI-Crafted care plan aims to stop a common ICU harm
Prevention Not yet recruitingThis trial tests whether a nursing care bundle created with the help of artificial intelligence can prevent medical device-related pressure injuries in intensive care patients. These injuries, which can be painful and serious, affect about 1 in 5 ICU patients. The study will comp…
Sponsor: Koç University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can AI protect Kids' eyesight where eye doctors are scarce?
Prevention Not yet recruitingResearchers are testing whether an artificial intelligence tool can sort children by their risk of nearsightedness and guide personalized prevention, such as more outdoor time and special glasses. The trial enrolls about 1,600 students in grades 1 through 3 from public primary sc…
Sponsor: Shanghai Eye Disease Prevention and Treatment Center • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Zapping the ear: a new way to stop Post-Surgery heart rhythm problems?
Prevention Not yet recruitingResearchers are testing whether mild electrical stimulation of a nerve in the ear can prevent atrial fibrillation, a common irregular heartbeat, after off-pump coronary artery bypass surgery. Adults scheduled for this heart surgery receive either the stimulation plus standard car…
Sponsor: Ruijin Hospital • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can a smarter program help more people avoid diabetes?
Prevention Not yet recruitingThis study tests whether an enhanced version of the Intensive Diabetes Prevention Program (IDPP) works better than the standard program at recruiting and keeping participants in district health centres. Researchers will compare the two approaches in 170 adults with prediabetes, l…
Sponsor: The Hong Kong Polytechnic University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
New program aims to stop elder abuse in dementia caregiving
Prevention Not yet recruitingThis study tests an 8-week program called KINDER, designed to help family caregivers of people with dementia reduce psychological elder abuse and improve the quality of care. The program includes group discussions over Zoom and a self-paced workbook. Researchers will enroll 260 c…
Sponsor: Case Western Reserve University • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Can one visit cover HPV and tetanus protection? a phase 3 trial puts the question to the test
Prevention Not yet recruitingResearchers are testing whether a quadrivalent HPV vaccine can be given at the same time as a tetanus-diphtheria booster in healthy children and adolescents aged 9 to 15 in Indonesia. The trial compares children who receive both vaccines together with those who receive the HPV va…
Phase 3 • Sponsor: PT Bio Farma • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Chilling the pancreatic duct opening: can ice water cut Post-ERCP pancreatitis?
Prevention Not yet recruitingPancreatitis is a painful inflammation of the pancreas that can happen after an ERCP procedure. Doctors often give rectal indomethacin around the time of ERCP to lower that risk, but it still occurs. This trial randomly assigns adults having ERCP to receive either rectal indometh…
Sponsor: Unity Health Toronto • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Pinpointing the dose: can phenylephrine keep blood pressure steady during cesarean birth?
Prevention Not yet recruitingSpinal anesthesia for cesarean delivery often causes a sudden drop in blood pressure. Researchers are testing different infusion rates of phenylephrine, a drug that narrows blood vessels, to find the dose that prevents this drop in most women. The trial enrolls 200 women with ful…
Phase 4 • Sponsor: Peking University People's Hospital • Aim: Prevention
Last updated Sep 19, 2026 00:00 UTC
-
Nepal trial tests community program to prevent lung disease
Prevention Not yet recruitingThis study tests whether a program led by community health workers can improve lung health for 800 people in Bhaktapur, Nepal, who are at risk for chronic respiratory diseases. The program includes tobacco cessation counseling, mask use during high pollution, handwashing, and flu…
Phase 4 • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Tiny tweets, big impact? testing digital nudges to boost HIV prevention
Prevention Not yet recruitingResearchers at Emory University are running a rapid randomized controlled trial to see if small changes to digital messages and website design can help more people start and stay on HIV prevention medication (PrEP) through telehealth. The study includes adults in the United State…
Sponsor: Emory University • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can a Pre-Surgery nerve block stop years of chest pain after heart surgery?
Prevention Not yet recruitingChronic pain after heart surgery through a breastbone incision affects many patients and can last for years. Researchers are testing whether an ultrasound-guided nerve block, given after anaesthesia but before the first cut, can reduce the chance of chronic pain three months late…
Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can a new drug wipe out hidden cancer DNA and stop colorectal cancer from returning?
Prevention Not yet recruitingResearchers are testing an experimental drug called INCA33890 in people with stage II or III colorectal cancer who have finished surgery and chemotherapy but still have tiny amounts of tumor DNA in their blood. This leftover DNA, called circulating tumor DNA or ctDNA, can signal …
Phase 2 • Sponsor: Incyte Corporation • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Double probe heat therapy may slash cervical cancer risk in HIV-positive women
Prevention Not yet recruitingThis study will test if using two heat probes instead of one can better prevent cervical cancer in 300 women with HIV in Zimbabwe. The standard single-probe treatment often fails in these women. The goal is to see if the two-probe method is safe, acceptable, and more effective at…
Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
A 10-Minute chat in the Doctor's office could teach teens to save a life
Prevention Not yet recruitingThis trial tests whether a short educational session during a routine primary care visit can help young people aged 13 to 26 understand overdose risks, recognize an overdose, and respond with naloxone. Providers in the intervention group deliver the education and offer naloxone a…
Sponsor: Boston Medical Center • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
New injectable HIV prevention drug tested in healthy volunteers
Prevention Not yet recruitingResearchers are testing a new injectable drug called VH5356136 to see if it is safe and how the body processes it. The trial enrolls about 160 healthy adults without HIV, ages 18 to 55. Participants receive a single dose of the drug or a placebo, and researchers monitor side effe…
Phase 1 • Sponsor: ViiV Healthcare • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Can olive oil and nuts in early pregnancy ward off gestational diabetes?
Prevention Not yet recruitingResearchers are testing whether an intensive Mediterranean diet program started in the first trimester of pregnancy lowers the chance of developing gestational diabetes in women at high risk. The trial enrolls about 1,200 pregnant women aged 18 to 50 with a single, unassisted pre…
Sponsor: Hospital San Carlos, Madrid • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
A digital coach may guide patients through cervical cancer prevention
Prevention Not yet recruitingThis trial tests whether an animated health coach on a smartphone can help people who have abnormal cervical cancer screening results get the follow-up care they need. Many people skip these appointments, which can lead to preventable cancer. The study will enroll 750 adults aged…
Sponsor: Tufts Medical Center • Aim: Prevention
Last updated Sep 18, 2026 00:00 UTC
-
Magnetic pulses to the brain target gambling cravings
Symptom relief Not yet recruitingResearchers at Sveti Ivan Psychiatric Hospital are testing whether high-frequency repetitive transcranial magnetic stimulation (rTMS) with the H7 coil reduces gambling disorder symptoms. The trial enrolls 60 men aged 18 to 64 who are starting treatment at a gambling disorder day …
Sponsor: Sveti Ivan Psychiatric Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Zapping a social brain region: can magnetic pulses help teens with autism read social cues?
Symptom relief Not yet recruitingResearchers are testing whether transcranial magnetic stimulation (TMS) can improve social perception in adolescents with autism spectrum disorder. The trial targets the right posterior superior temporal sulcus, a brain region involved in processing social information. Sixteen pa…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Knotless suture technique aims to hold rotator cuff repairs together like a hot air balloon
Symptom relief Not yet recruitingResearchers are studying a surgical method for repairing rotator cuff tears that uses two rows of anchors and sutures without knots, called the Montgolfier technique. The sutures spread tension evenly around the repair, similar to the cables of a hot air balloon. Adults scheduled…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a cannabis tincture quiet an anxious mind?
Symptom relief Not yet recruitingResearchers are studying whether a broad-spectrum oral tincture containing CBD, CBN, and CBG changes anxiety symptoms in adults with generalized anxiety disorder. About 60 participants will take the tincture under the tongue or by mouth roughly every 12 hours for 8 weeks, with fo…
Sponsor: Associação Pan-Americana Multidisciplinar de Endocanabinologia • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can High-Flow oxygen make heart valve surgery safer for seniors?
Symptom relief Not yet recruitingThis study tests whether giving high-flow oxygen through special nasal prongs during a less-invasive heart valve replacement (TAVR) can prevent low oxygen levels and breathing complications. About 452 older adults undergoing TAVR under sedation will be randomly assigned to receiv…
Sponsor: Hospital Clinic of Barcelona • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a Comfort-Focused education program improve life with epilepsy?
Symptom relief Not yet recruitingResearchers are testing whether a structured educational program based on Kolcaba's Comfort Theory can improve quality of life for adults with epilepsy. The program addresses physical, emotional, social, and environmental comfort needs through planned sessions delivered alongside…
Sponsor: Ataturk University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Could a poop transplant ease autism? small trial aims to find out
Symptom relief Not yet recruitingThis early-phase trial tests whether giving adults with autism a 6-week course of vancomycin followed by a fecal transplant from a close relative can improve social and language problems. Ten participants will be tracked for changes in autism symptoms, quality of life, and gut he…
Phase 1 • Sponsor: ProgenaBiome • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Cancer drug keytruda tested as possible treatment for long COVID brain fog
Symptom relief Not yet recruitingThis early-stage trial tests whether a single dose of pembrolizumab (Keytruda), a drug used for cancer, can safely reduce long-term neurological symptoms like brain fog and dizziness in people with long COVID. Fifteen adults who had COVID-19 at least six months ago and still have…
Phase 1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New pill aims to calm painful skin flares
Symptom relief Not yet recruitingResearchers are testing an experimental oral drug called soquelitinib in adults with moderate-to-severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps and tunnels. The trial aims to see if the drug is safe and can reduce the number of inflammatory le…
Phase 1 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
New study aims to find best therapy for angry outbursts in kids
Symptom relief Not yet recruitingThis study compares three types of therapy for children aged 8 to 16.5 with severe irritability. Participants will receive either exposure-based cognitive behavioral therapy, parent management training, or supportive psychoeducation over 12 sessions. The goal is to see which appr…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
A single zoom class might ease cancer pain for american indians
Symptom relief Not yet recruitingThis trial tests whether a single, two-hour online class called Empowered Relief can help American Indian adults with cancer-related pain. Participants learn three pain relief skills, create a personal plan, and get access to a free audio app for daily practice. The study aims to…
Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Two shockwave types go head to head for stubborn heel pain
Symptom relief Not yet recruitingResearchers are comparing two forms of shockwave therapy, focused and radial, for adults with chronic plantar fasciitis, a common cause of heel pain. About 150 participants receive three weekly treatment sessions and then answer questions about pain and foot function for up to a …
Sponsor: Homerton University Hospital NHS Foundation Trust • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can virtual reality help children with brain injury regain hand control?
Symptom relief Not yet recruitingResearchers compare two rehabilitation approaches for children with cerebral palsy and immature brain injury: virtual reality training and task-oriented circuit training. Both aim to improve upper limb sensorimotor function, pinch grip, and quality of life. Forty-four children ag…
Sponsor: October 6 University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can an AI chatbot help cancer patients kick the habit?
Symptom relief Not yet recruitingResearchers are testing whether an AI chatbot on WeChat helps early-stage cancer patients quit smoking. The chatbot uses the Multi-Theory Model to offer personalized advice, emotional support, and habit tracking around the clock. The trial compares the chatbot with phone-based pr…
Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a personal navigator help young cancer patients through treatment?
Symptom relief Not yet recruitingResearchers at the University of North Carolina are testing a support program for young adults aged 18 to 39 who are receiving cancer treatment. A trained navigator contacts each participant at least once a month for four months by phone, text, email, or video, based on what the …
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Brain scans vs tape measures: which TMS targeting works best for depression?
Symptom relief Not yet recruitingThis study tests whether using a person's brain scan (MRI) to guide TMS treatment for depression works better than the standard scalp-measurement method. 160 adults with major depression will receive accelerated TMS (10 sessions a day for 5 days) with either MRI or scalp targetin…
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a phone app that blocks distracting apps ease depression?
Symptom relief Not yet recruitingResearchers at the University of Bergen are testing whether a two-week, self-guided smartphone screen time reduction program can reduce depression symptoms in young adults. The trial enrolls 200 students in Oslo who have sought help at the student mental health service. Participa…
Sponsor: University of Bergen • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can adding common pain drugs reduce morphine needs in sickle cell crises?
Symptom relief Not yet recruitingAdults with sickle cell disease often face severe pain crises that require hospital treatment with intravenous morphine. This trial compares standard morphine treatment with combinations that add paracetamol, ketamine, or nefopam. Researchers want to see if these combinations eas…
Phase 4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Nurse-Led asthma program aims to help patients breathe easier
Symptom relief Not yet recruitingThis pilot study tests a 12-month structured nursing program called RESPiraIA-Asma for adults with poorly controlled, non-severe asthma. The program combines education, inhaler training, home peak-flow monitoring, and personalized care plans, offered in-person, digitally, or mixe…
Sponsor: Hospital San Carlos, Madrid • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can Pre-Surgery pelvic floor therapy stop endometriosis pain after the operation?
Symptom relief Not yet recruitingEndometriosis is a long-term condition where tissue like the uterine lining grows outside the uterus, often causing lasting pelvic pain. Surgery can help, but pain sometimes remains afterward. Researchers are testing whether a structured pelvic floor physiotherapy program done be…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Could a special screen light reduce tired eyes and dryness?
Symptom relief Not yet recruitingThis study tests whether a full-spectrum screen bar light can reduce eye fatigue and dry eye symptoms after two hours of computer work. Healthy adults aged 18 to 35 who use screens at least four hours daily will be randomly assigned to use the light or a standard screen without i…
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a Five-Session therapy ease distress and calm stress biology in Late-Stage breast cancer?
Symptom relief Not yet recruitingResearchers are testing a five-session meaning-centered psychotherapy called CASA in Puerto Rican patients with Stage III or IV breast cancer and their caregivers. The trial compares CASA with usual care in about 114 people to see whether the therapy reduces psychological distres…
Phase 1 • Sponsor: Ponce Medical School Foundation, Inc. • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Allergy pill put to the test against endometriosis pain
Symptom relief Not yet recruitingEndometriosis causes chronic pelvic pain and painful periods, and current treatments do not work for everyone. Researchers are testing whether desloratadine, an antihistamine usually taken for allergies, can reduce pain and improve quality of life. The trial enrolls 60 women aged…
Phase 2 • Sponsor: Medical University of Vienna • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can mindfulness and yoga rewire diabetes habits?
Symptom relief Not yet recruitingResearchers are testing a program that combines mindful eating and yoga-based movement for adults with type 2 diabetes. The trial enrolls 60 people aged 40 and older who have had diabetes for at least six months. Half receive the mindfulness program and half receive standard diet…
Sponsor: Northeastern University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Marijuana pill may boost CPAP use in sleep apnea patients
Symptom relief Not yet recruitingThis study tests whether taking dronabinol (a cannabis-derived medication) before bed can help people with obstructive sleep apnea use their CPAP machine more consistently. Researchers will also check if combining CPAP with dronabinol improves sleep quality and blood pressure. Th…
Phase 2/3 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a breathing workout and walks help dialysis patients with irregular heartbeats?
Symptom relief Not yet recruitingResearchers test whether adding inspiratory muscle training to a walking program helps adults on hemodialysis who also have atrial fibrillation. Participants do breathing exercises through a mouthpiece and walk for six minutes, while the study tracks heart rate, blood pressure, k…
Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can jaw and neck exercises ease TMJ pain?
Symptom relief Not yet recruitingResearchers test whether a combination of orofacial myofunctional therapy and cervical stabilization exercises can reduce jaw pain and improve function in adults with anterior disc displacement with reduction, a common temporomandibular disorder. The trial enrolls 80 adults aged …
Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can virtual reality rewire balance and leg control in cerebral palsy?
Symptom relief Not yet recruitingResearchers compare two exercise-based therapies for children with spastic cerebral palsy: virtual reality therapy and plyometric exercise training. The trial enrolls 44 children aged 12 to 18 who can stand alone and have mild to moderate mobility limits. Children in the virtual …
Sponsor: October 6 University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can focused electrical fields deep in the brain ease Parkinson's tremors?
Symptom relief Not yet recruitingResearchers at Tongji Hospital are testing a non-invasive brain stimulation technique called transcranial temporal interference stimulation (tTIS) in 26 people with Parkinson's disease. The study uses MRI scans to customize electrode placement so the stimulation reaches deep brai…
Sponsor: Tongji Hospital • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can pressing six points on the body help older adults sleep?
Symptom relief Not yet recruitingResearchers are testing whether older adults with high blood pressure who report insomnia can improve their sleep by pressing six acupoints on themselves each night for 28 days. The trial compares this self-acupressure routine with sleep hygiene training in 94 participants aged 6…
Sponsor: Phenikaa University • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Can a Self-Balancing exoskeleton make daily tasks more satisfying than a wheelchair?
Symptom relief Not yet recruitingResearchers compare how people with paraplegia perform and feel about four daily tasks when using a self-balancing exoskeleton versus a manual wheelchair. Five participants attend daily sessions where they do tasks like making coffee or brushing teeth with each device. The study …
Sponsor: Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Teaching the brain to tame pain: a virtual approach to enhance spinal cord stimulation
Symptom relief Not yet recruitingThis pilot trial tests whether adding virtual pain neuroscience education to standard spinal cord stimulation can help chronic pain patients better manage their condition. The education teaches how the brain processes pain, aiming to reduce fear, anxiety, and catastrophizing. Par…
Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a weekly weight drug quiet gout attacks?
Symptom relief Not yet recruitingResearchers are testing whether mazdutide, a weekly injected drug, reduces the number of gout flares in adults who have both obesity and gout. The study enrolls 30 people aged 18 to 65 with a BMI of at least 30 and at least two gout flares in the past six months. Everyone receive…
Phase 4 • Sponsor: Hongwei Jiang • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a video game teach cancer patients to tame their pain?
Symptom relief Not yet recruitingResearchers at Dana-Farber Cancer Institute are testing Healing Gardens, a mobile game that delivers pain-focused cognitive behavioral therapy and cancer pain education. The study enrolls 46 adults with advanced solid tumors who have chronic pain related to cancer or its treatmen…
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Cash rewards and coaching put to the test for Post-Surgery walking
Symptom relief Not yet recruitingMany people with lumbar spinal stenosis get pain relief from decompression surgery but still do not walk more afterward. This pilot trial tests whether a behavioral program can change that. Researchers randomly assign 75 patients aged 40 to 85 to either the program, which pairs m…
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a free online program ease social anxiety? new study aims to find out.
Symptom relief Not yet recruitingThis study tests an online self-help tool called e-couch for adults with social anxiety. Over 5 weeks, 200 participants will use the program, which is based on cognitive behavioral therapy. Researchers will use surveys and computer tasks to predict who improves the most.
Sponsor: Trustees of Princeton University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New mask aims to make sleep apnea therapy easier to live with
Symptom relief Not yet recruitingResearchers are testing the F&P Licorice mask, a device used with PAP or NIV breathing machines, in people who have obstructive sleep apnea or other chronic respiratory conditions. The study follows about 45 adults who already use this type of therapy at home. Over roughly two we…
Sponsor: Fisher and Paykel Healthcare • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can spiritual workshops ease Cancer's existential pain?
Symptom relief Not yet recruitingThis study tests a spiritual health program called PATH for cancer patients struggling with feelings of disconnection, loss of meaning, or existential distress. Twenty adults with any stage of cancer will attend six workshops combining role-playing, psychology, and dignity therap…
Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Nerve blocks put to the test for chest tube pain
Symptom relief Not yet recruitingDoctors insert a chest tube to drain air or fluid from around the lungs, but the procedure often causes severe pain. This trial compares two ultrasound-guided nerve blocks, the serratus anterior plane block and the erector spinae plane block, to see which one better controls pain…
Sponsor: Assiut University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Veterans with opioid addiction may soon get pain relief from a web program
Symptom relief Not yet recruitingThis Phase 3 trial will test a web-based program called IMPACT for 250 veterans who have both opioid use disorder and chronic pain. The program includes 9 online modules and weekly feedback from a coach, all done from home. The goal is to see if it reduces how much pain interfere…
Phase 3 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
AI chatbot aims to demystify prostate cancer radiation — a trial puts it to the test
Symptom relief Not yet recruitingThis trial tests whether an artificial intelligence chatbot can help men with prostate cancer better understand radiation therapy. Participants will use a plain-language chatbot alongside standard education from their care team. Researchers will measure changes in patients' confi…
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a faster recovery plan get kids home sooner after ileostomy reversal?
Symptom relief Not yet recruitingResearchers compare two approaches to care after ileostomy reversal surgery in children. One group receives the Enhanced Recovery After Surgery (ERAS) protocol, which includes early feeding, early catheter removal, early walking, and multimodal pain control. The other group recei…
Sponsor: Children Hospital Faisalabad • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Two sedatives, one question: can remimazolam shield the brain during aortic arch surgery?
Symptom relief Not yet recruitingAortic arch surgery temporarily cuts blood flow to the brain, which can leave patients with lasting thinking and memory problems. Researchers at Seoul National University Hospital are testing whether anesthesia with remimazolam, rather than propofol, lowers the chance of that cog…
Phase 4 • Sponsor: Seoul National University Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New study tests if helping others can spark motivation in dementia patients
Symptom relief Not yet recruitingThis study tests two simple activities—volunteering inside the assisted living community or joining a current events discussion group—to see if they can reduce apathy in residents with mild to moderate memory problems. About 200 people aged 55 and older will take part for 6 month…
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could fasting ease the misery of pancreatitis?
Symptom relief Not yet recruitingResearchers are testing whether intermittent fasting improves quality of life for adults with acute or chronic pancreatitis. Participants follow a daily 16-hour fast or receive standard calorie guidance. The study measures pancreas-related quality of life, pain, opioid use, weigh…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can VR lessons help heart patients take their medicines?
Symptom relief Not yet recruitingResearchers are testing whether nurse-led lessons delivered through virtual reality or a tablet help people with coronary artery disease understand their heart risks and take their antiplatelet medicines as prescribed. The trial enrolls 54 adults aged 18 to 65 who have coronary a…
Sponsor: Abant Izzet Baysal University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can an antipsychotic restore feelings in people with depression?
Symptom relief Not yet recruitingResearchers test whether adding lumateperone to ongoing antidepressant treatment reduces emotional blunting in adults with major depressive disorder. Emotional blunting means feeling numb or unable to experience pleasure or sadness. Thirty participants who score high on the Oxfor…
Phase 4 • Sponsor: Future Options Research, LLC • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could a gut drug boost brain power in schizophrenia?
Symptom relief Not yet recruitingThis study tests whether prucalopride, a drug used for gut issues, can improve thinking and memory in people with schizophrenia. About 34 adults will take the drug for 4 weeks while staying on their usual medications. Researchers will measure changes in memory, attention, and pro…
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a sugary drink before Weight-Loss surgery speed up gut recovery?
Symptom relief Not yet recruitingResearchers are testing whether a carbohydrate-rich clear drink given two hours before bariatric surgery helps patients with metabolic syndrome recover normal gastrointestinal function faster. About 208 adults scheduled for gastric bypass or sleeve gastrectomy will be randomly as…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
A single shot into the ear: can a new drug quiet constant ringing?
Symptom relief Not yet recruitingResearchers are testing whether a one-time injection of an experimental drug called paliroden into the middle ear is safe and can help adults with chronic, constant tinnitus in both ears. Participants, ages 18 to 75, have normal hearing thresholds but struggle to understand speec…
Phase 1/2 • Sponsor: Cilcare SAS • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Nerve-Block procedure tested against severe pancreatic and stomach cancer pain
Symptom relief Not yet recruitingResearchers are studying whether a procedure called fluoroscopy-guided transdiscal splanchnic nerve neurolysis can safely reduce severe upper abdominal pain in adults with pancreatic, gastric, or hepatobiliary cancer. Participants first receive a diagnostic nerve block with local…
Sponsor: Sahiwal medical college sahiwal • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Knee pain relief: targeted exercises show promise in small trial
Symptom relief Not yet recruitingThis study tests two types of exercise for people with a common knee condition called patellofemoral pain. One group does neuromuscular control exercises (like balance and coordination), the other does muscle strengthening. Researchers will measure pain, function, and movement in…
Sponsor: Universidade do Porto • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can electrical muscle stimulation boost exercise benefits after menopause?
Symptom relief Not yet recruitingResearchers are testing whether adding whole-body electromyostimulation (WB-EMS) to a supervised exercise program improves body composition, heart health, fitness, and quality of life in overweight or obese postmenopausal women. Thirty women aged 48 to 60 will join a 16-week prog…
Sponsor: High Institute of Sports and Physical Education of Kef • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can mindfulness help unhoused LGBTQ youth thrive? new study aims to find out.
Symptom relief Not yet recruitingThis study tests whether brief mindfulness and identity-affirming exercises can improve well-being and reduce mental health symptoms in LGBTQ youth aged 16-26 who are currently or recently unhoused. Two hundred participants will be randomly assigned to either the mindfulness prog…
Early phase 1 • Sponsor: Cornell University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a single drug dose curb opioid side effects after kidney stone surgery?
Symptom relief Not yet recruitingResearchers test whether a single intravenous dose of anrikefon, given near the end of kidney stone removal surgery, can reduce opioid-related side effects such as nausea, vomiting, itching, oversedation, and breathing problems in the first 24 hours after surgery. All 160 adult p…
Phase 4 • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a Post-Training drink help young footballers recover and sleep better?
Symptom relief Not yet recruitingResearchers are testing whether a dietary supplement called KA-EX helps young elite football players recover after training. Players on the Udine Primavera team receive either KA-EX or a placebo powder mixed in water right after training for two months. The team tracks heart rate…
Sponsor: Antonio Molina Lopez • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a 10-Hour eating window fight cancer fatigue?
Symptom relief Not yet recruitingResearchers are testing whether time-restricted eating, where all food is eaten within a 10-hour window each day, can reduce fatigue and slow frailty in older adults living with prostate cancer or metastatic breast cancer. The trial enrolls 132 people aged 55 and older who typica…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?
Symptom relief Not yet recruitingMany people treated with aromatase inhibitors for early-stage breast cancer develop joint pain and stiffness that can make it hard to continue the therapy. This Phase II pilot study tests whether hydroxychloroquine, an anti-inflammatory drug often used for inflammatory joint cond…
Phase 2 • Sponsor: Indiana University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Microwave needle tested as Scar-Free fix for benign breast lumps
Symptom relief Not yet recruitingResearchers are testing whether ultrasound-guided microwave ablation can safely treat breast fibroadenomas, which are non-cancerous lumps that can cause pain or change the shape of the breast. The procedure uses a thin needle to deliver heat that destroys the lump under local ane…
Sponsor: Al-Azhar University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can tango rewire the brain? dance program tested for Parkinson's and dementia
Symptom relief Not yet recruitingResearchers at Emory University are studying a modified Argentine tango program called Adaptango for adults with Parkinson's disease, mild cognitive impairment, or dementia, alongside younger adults. Over three months, participants take part in biweekly choreographic sessions tha…
Sponsor: Emory University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a common bleeding drug make knee realignment surgery safer?
Symptom relief Not yet recruitingResearchers are testing whether tranexamic acid, a drug that helps prevent bleeding, reduces blood loss and wound complications during high tibial osteotomy. This surgery realigns bow-legged knees to ease osteoarthritis pain and slow joint damage. The trial enrolls 200 adults wit…
Phase 3 • Sponsor: Western University, Canada • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a phone app help pancreatic cancer patients eat better during treatment?
Symptom relief Not yet recruitingResearchers are testing whether a digital nutrition app called STRONG, paired with remote dietitian counseling, is practical and helpful for adults with pancreatic ductal adenocarcinoma who are starting chemotherapy or radiation. About 80 participants join the study and are assig…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can talk therapy rewire the brain to ease burn Survivors' pain?
Symptom relief Not yet recruitingMany burn survivors live with persistent pain that disrupts daily life, and negative thoughts about pain can make it worse. Researchers are testing an 8-week cognitive behavioral therapy program delivered by video to see if it reduces pain interference and pain catastrophizing mo…
Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a light bulb dial down chronic pain?
Symptom relief Not yet recruitingResearchers at the University of North Carolina at Chapel Hill are testing whether daily exposure to S-cone stimulating colored light can reduce pain severity and pain sensitivity in adults with fibromyalgia or chronic widespread pain and fatigue. Participants use programmed ligh…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Can a new drug shield kidneys from chemotherapy damage?
Symptom relief Not yet recruitingResearchers are testing an experimental drug called GMDTC in adults with solid tumors who have mild kidney problems caused by cisplatin chemotherapy. The trial aims to find out if GMDTC is safe, what side effects it causes, and how the body processes it. Participants receive cisp…
Phase 1 • Sponsor: Guangdong Jianersheng Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Exercise at home may be the new painkiller for period cramps
Symptom relief Not yet recruitingThis study tests whether an 8-week home exercise program can reduce pain and improve walking and brain function in young women with painful periods. Eighty-six single women aged 18-25 with moderate to severe period pain will do 30-minute sessions three times a week, including rel…
Sponsor: University of Sharjah • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Heel pain Face-Off: nerve zapping vs. Blood-Based injection vs. both
Symptom relief Not yet recruitingPlantar fasciitis causes heel pain when the tissue supporting the foot arch degenerates. Standard treatments like physical therapy, anti-inflammatory drugs, and orthotics help most people, but some continue to have pain for months. Researchers are testing three ultrasound-guided …
Sponsor: Assiut University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Could early palliative care reduce aggressive End-of-Life cancer treatments?
Symptom relief Not yet recruitingThis study looks at whether bringing in palliative care early during an unplanned hospital stay can reduce aggressive treatments at the end of life for people with advanced cancer. About 493 adults with metastatic digestive, gynecological, ENT, or sarcoma cancers will be randomly…
Sponsor: Centre Oscar Lambret • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
New drug tested to curb pain after liver surgery
Symptom relief Not yet recruitingResearchers test anrikefon injection to see if it eases pain after laparoscopic liver surgery. Adults aged 18 to 75 scheduled for this operation receive either anrikefon or flurbiprofen after surgery. The trial measures pain scores over 24 hours and checks for side effects.
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Radiofrequency heat vs. exercise for aching shoulders
Symptom relief Not yet recruitingResearchers test whether TECAR therapy, a radiofrequency treatment that warms deep shoulder tissues, adds benefit to a standard exercise program for people with rotator cuff tendinopathy. Thirty-six participants receive either TECAR plus exercise or exercise alone. The trial meas…
Sponsor: Ayşe Ukbe Baykut • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Psilocybin and brain training: a new frontier for aging minds?
Symptom relief Not yet recruitingThis Phase 2 trial tests whether combining psilocybin—a compound from certain mushrooms—with daily cognitive training can enhance brain plasticity in adults aged 65 and older. Participants include healthy older adults and those with mild cognitive impairment or early-stage Alzhei…
Phase 2 • Sponsor: National Institute on Aging (NIA) • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Starving brain tumors of blood before surgery
Symptom relief Not yet recruitingSome brain tumors, including meningiomas, hemangioblastomas, and certain metastases, have a rich blood supply that makes surgical removal difficult and risky. This study tests whether blocking the tumor's feeding blood vessels with a catheter procedure before surgery reduces blee…
Sponsor: Assiut University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Two therapy approaches go Head-to-Head for Children's arm movement
Symptom relief Not yet recruitingResearchers compare two rehabilitation methods for children with hemiplegic cerebral palsy, a condition that causes muscle tightness and limited arm movement on one side. The trial enrolls 40 children aged 8 to 12 who receive either electromyography biofeedback training, which us…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a starch powder trick the gut into curbing teen appetite?
Symptom relief Not yet recruitingResearchers at Indiana University are testing whether a food carbohydrate powder made from raw corn and potato starch can raise levels of GLP-1, a gut hormone that helps people feel full. The trial enrolls 62 adolescents aged 12 to 18 with obesity. For two months, participants dr…
Phase 2 • Sponsor: Indiana University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can leaving a sliver of tooth root save your smile after an implant?
Symptom relief Not yet recruitingResearchers compare two methods for replacing a missing front upper tooth with an implant right after extraction. One method, the Socket-Shield technique, leaves a thin piece of the tooth root in place to help protect the jawbone and gums. The other method uses the standard appro…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Iron infusions put to the test against stubborn restless legs
Symptom relief Not yet recruitingResearchers are testing whether intravenous ferric carboxymaltose, an iron replacement, eases severe restless legs syndrome that has not responded to standard drugs. The trial enrolls 66 adults with drug-resistant RLS and assigns them to receive the infusion either right away or …
Phase 2 • Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can zapping the ear calm HIV nerve pain?
Symptom relief Not yet recruitingResearchers at the University of Miami are testing a non-invasive ear stimulation treatment to understand nerve pain in older adults living with HIV. The study enrolls 70 people with HIV-associated peripheral neuropathy, a condition that causes tingling, numbness, or pain in the …
Sponsor: University of Miami • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a Dietitian's plan help older pancreatic cancer patients feel better?
Symptom relief Not yet recruitingResearchers are testing whether personalised nutritional care from a trained dietitian improves quality of life for people aged 65 and older with pancreatic ductal adenocarcinoma. About 250 participants will be randomly assigned to either six months of individualised nutrition su…
Sponsor: Inna Chen, MD • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a single talk session help cancer patients quit smoking?
Symptom relief Not yet recruitingResearchers test whether adding one structured cognitive behavioral therapy session to standard brief quit-smoking advice helps cancer patients stop smoking. The trial enrolls 446 adults with cancer in Vietnam who smoked at diagnosis and still smoke. Everyone gets brief counselin…
Sponsor: Nguyen Duc Khoa, MD, PhD • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could a wearable zapper quiet cirrhosis pain without drugs?
Symptom relief Not yet recruitingResearchers at the University of Michigan are studying whether a home device called Transcutaneous Electrical Acustimulation (TEA) can help adults with cirrhosis manage chronic pain. The trial enrolls 100 people who report ongoing pain on most days. Participants use either a real…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Ancient music therapy put to the test against anxiety in pancreatic cancer
Symptom relief Not yet recruitingThis trial tests whether a traditional Chinese music therapy, called Ziwu Liuzhu Five-Element Music Therapy, can reduce anxiety in people with pancreatic cancer who are undergoing chemotherapy. The study will enroll 320 patients with mild-to-moderate anxiety and randomly assign t…
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can orange peel gel soothe radiation mouth sores?
Symptom relief Not yet recruitingResearchers are testing a gel made from orange peel extract to see if it can reduce the severity of mouth sores caused by radiation therapy in people with head and neck cancer. Thirty adults receiving radiation will be split into two groups: one gets the orange peel gel, the othe…
Sponsor: Alexandria University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can VR games restore lost vision in young brain tumor survivors?
Symptom relief Not yet recruitingThis study tests whether a virtual reality program can improve vision in 120 children, teens, and young adults who have lost part of their visual field (hemianopsia) after a brain tumor. Participants will use a VR headset at home for 8 weeks to do visual exercises. The goal is to…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Keyhole vs open surgery: which appendectomy works better for obese patients?
Symptom relief Not yet recruitingResearchers compare two surgical methods for removing an inflamed appendix in obese patients: laparoscopic (keyhole) surgery and traditional open surgery. The trial enrolls 166 obese adults with acute appendicitis, randomly assigning each to one of the two procedures. The main go…
Sponsor: University of Health Sciences Lahore • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Tiny horses, big lessons: can ponies help kids tame diabetes?
Symptom relief Not yet recruitingResearchers are testing a diabetes education program that combines standard self-management lessons with hands-on activities involving miniature horses. Children and teens ages 8 to 20 with type 1 or type 2 diabetes, along with their caregivers, attend four sessions led by a diab…
Sponsor: Nemours Children's Clinic • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a simple IV drip replace nerve blocks for breast surgery pain?
Symptom relief Not yet recruitingResearchers are testing whether an intravenous lidocaine infusion works as well as a thoracic paravertebral nerve block for helping women recover after breast cancer surgery. The trial enrolls 112 adults scheduled for mastectomy or breast-conserving surgery. Participants receive …
Sponsor: Mahidol University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a common toxin calm Parkinson's shaking hands?
Symptom relief Not yet recruitingMany people with Parkinson's disease develop hand tremor that standard drugs cannot control. This Phase 3 trial tests whether botulinum toxin injections, guided by each patient's tremor pattern, can reduce that shaking. Participants receive either the toxin or a placebo injection…
Phase 3 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Exercise after chemo: could a simple walking program protect your heart?
Symptom relief Not yet recruitingThis study looks at whether an 8-week aerobic exercise program can improve blood vessel function in women who have finished chemotherapy for non-metastatic breast cancer. Forty women will exercise three times a week for 30 minutes at a moderate pace. Researchers will measure arte…
Sponsor: Loyola University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Breathing your way to better heart health: new POTS study
Symptom relief Not yet recruitingThis study tests whether regular breathing exercises can improve symptoms of Postural Tachycardia Syndrome (POTS), a condition that causes dizziness and rapid heartbeat when standing. Twelve adults with POTS will practice breathing exercises daily for four weeks while researchers…
Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can an experimental drug ease a pregnancy liver condition?
Symptom relief Not yet recruitingIntrahepatic cholestasis of pregnancy is a liver condition that causes severe itching and can pose risks to both mother and baby. Researchers are testing whether an oral drug called maralixibat is safe and well tolerated in pregnant women with this condition. All 15 participants …
Phase 2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Shorter radiation course tested for advanced head and neck cancer
Symptom relief Not yet recruitingResearchers compare two palliative radiation schedules for people with incurable head and neck cancer. The standard Split Course takes several weeks and often causes hard-to-tolerate side effects. The study tests whether a shorter Quad Shot regimen can shrink tumors and ease symp…
Sponsor: Instituto Nacional de Cancerologia, Columbia • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could kids with bone cancer go home sooner after chemo?
Symptom relief Not yet recruitingThis study looks at whether children, teens, and young adults with newly diagnosed osteosarcoma can safely leave the hospital when their methotrexate levels are slightly higher than usual after standard chemotherapy. The goal is to shorten hospital stays without increasing side e…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Tiny camera could make knee surgery less painful
Symptom relief Not yet recruitingResearchers compare two ways to perform knee surgery for simple problems like meniscal tears, cartilage damage, and loose bodies. One method uses a needle arthroscopy with a 1.9mm camera through tiny openings, and the other uses standard arthroscopy. Adults aged 18 to 65 join the…
Sponsor: Panam Clinic • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
New nose drop study aims to bring back lost smell for sinusitis sufferers
Symptom relief Not yet recruitingThis study compares two ways to give steroid medicine to people with chronic sinusitis who have lost their sense of smell due to blocked nasal passages. One group will get standard steroid spray, while the other gets steroid drops placed directly where smell happens. The goal is …
Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can DBT skills ease emotional distress after a first psychotic episode?
Symptom relief Not yet recruitingThis study tests whether an 8-week group program teaching dialectical behaviour therapy (DBT) skills is feasible and acceptable for people aged 14–35 who have experienced a first episode of psychosis. The program focuses on managing emotions, tolerating distress, and improving re…
Sponsor: Centre for Addiction and Mental Health • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can teaching parents about sleep help kids with developmental conditions?
Symptom relief Not yet recruitingMany preschoolers with neurodevelopmental disorders struggle with sleep, which can worsen behavior and stress at home. This Hong Kong trial compares two ways of teaching parents sleep strategies: group sessions in person and a self-help mobile app, both added to usual care, again…
Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a new pill stop migraine pain within two hours?
Symptom relief Not yet recruitingThis trial tests whether an experimental oral drug called BR005-036C can quickly relieve migraine attacks in adults. Researchers will compare two doses of the drug against a placebo in about 2,079 people who have migraines with or without aura. The main goals are to see if the dr…
Phase 2/3 • Sponsor: Brise Pharmaceuticals Co., Ltd. • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Catheter delivers numbing medicine from inside the vein to spare patients injection pain
Symptom relief Not yet recruitingResearchers are testing a new device called the Solutio™ catheter to see if it can safely deliver numbing medicine (tumescent anesthesia) from inside the great saphenous vein before endothermal ablation, a common treatment for varicose veins. The trial enrolls 30 adults with veno…
Sponsor: MedVasc AB • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Self-Balancing exoskeleton could let SCI patients walk without crutches
Symptom relief Not yet recruitingThis study tests whether a self-balancing exoskeleton called XoMotion-R can help people with spinal cord injury (SCI) walk hands-free during rehab. Researchers will recruit 16 participants (8 inpatients and 8 outpatients) with specific levels of SCI to try the device. The goal is…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Could a simple pillow be the key to better recovery after rotator cuff surgery?
Symptom relief Not yet recruitingThis study looks at whether using a pillow placed behind the shoulder after rotator cuff repair surgery can lower pain and improve sleep. About 126 adults aged 40 to 70 will choose whether to use the pillow or not. Their pain, sleep quality, and shoulder function will be checked …
Sponsor: Peking University Third Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
New study to uncover why stem cell transplants harm the liver
Knowledge-focused Not yet recruitingThis study follows 500 adults and children who are getting a stem cell transplant to see how their liver is affected. Researchers will track liver function, perform biopsies and scans, and look for factors that lead to liver damage. The goal is to better understand and eventually…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
A tiny touch test aims to map lost sensation in the throat
Knowledge-focused Not yet recruitingResearchers at the University of California, San Francisco are studying how well a calibrated touch device measures sensation in the larynx and throat. The study includes adults with larynx or throat disorders, including those whose condition followed radiation or other cancer tr…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Underactive thyroid may worsen liver scarring in fatty liver disease
Knowledge-focused Not yet recruitingResearchers at Assiut University are studying whether an underactive thyroid makes liver scarring worse in people with metabolic dysfunction-associated steatotic liver disease (MASLD). The trial enrolls 120 adults with MASLD, half of whom have overt or subclinical hypothyroidism …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Ambulance video calls could revolutionize stroke triage
Knowledge-focused Not yet recruitingThis study tests whether having a neurologist consult via video during ambulance transport helps decide the best hospital for suspected stroke patients. About 484 adults with stroke symptoms will be randomly assigned to standard care or standard care plus a telemedicine consultat…
Sponsor: Nyika D. Kruyt • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Brain scans reveal clues to ADHD and OCD in teens
Knowledge-focused Not yet recruitingThis study looks at brain activity in teenagers aged 10 to 17 with ADHD, OCD, or no diagnosis. Researchers will use EEG, MRI, and MEG to measure brain signals while participants do computer tasks. The goal is to understand how the brain controls thinking and behavior, which may h…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can four minutes of hard exercise match a longer workout for blood sugar?
Knowledge-focused Not yet recruitingResearchers at the University of California, San Francisco are testing whether short bursts of high-intensity exercise control blood sugar as well as longer, moderate workouts. The study enrolls 12 non-diabetic or pre-diabetic adults who wear a continuous glucose monitor for 11 d…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study to uncover why bhutanese americans face higher heart risks
Knowledge-focused Not yet recruitingThis natural history study will explore how life experiences and environmental factors affect heart health and metabolism among 50 Bhutanese adults living in the US. Participants will complete a survey and discuss their views on providing biological samples. The goal is to identi…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can difficulty naming emotions shape how much tailbone pain you feel?
Knowledge-focused Not yet recruitingResearchers at Marmara University are studying whether alexithymia, a trait where people struggle to identify and describe their feelings, relates to pain intensity, quality of life, anxiety, depression, and childhood trauma in adults with chronic coccydynia. Participants have ha…
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Desk jobs and aching bodies: what Lawyers' activity levels reveal
Knowledge-focused Not yet recruitingResearchers at Suleyman Demirel University are surveying lawyers registered with the Isparta Bar Association to understand how physical activity, stress, burnout, and job satisfaction relate to musculoskeletal pain. About 102 lawyers with at least five years of experience answer …
Sponsor: Suleyman Demirel University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New pain test battery could speed up drug development
Knowledge-focused Not yet recruitingThis pilot study will test a new method to see how two pain medicines, naproxen and pregabalin, work in healthy adults. Up to 25 participants will receive each medicine and a placebo in random order. They will undergo several short, controlled pain tests, like a cold water hand b…
Sponsor: National Center for Complementary and Integrative Health (NCCIH) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can better nurse training reduce ICU complications?
Knowledge-focused Not yet recruitingThis trial tests whether a structured training program for ICU nurses, focusing on respiratory and renal care with case-based discussions, improves their clinical reasoning, knowledge, and collaboration with doctors. The study involves 140 participants, including nurses and mecha…
Sponsor: Hiroshima University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Could you help scientists unlock genetic cancer secrets?
Knowledge-focused Not yet recruitingThis study screens up to 1,000 people with personal or family histories of certain cancers to see if they qualify for ongoing genetics research at the National Cancer Institute. Participants fill out a 15-20 minute online survey about their health and family history. No treatment…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can your nose predict brain health? new study tests smell and choices in HIV and addiction
Knowledge-focused Not yet recruitingThis study looks at how HIV and substance use disorder (SUD) affect the sense of smell and decision-making. Researchers will test 120 adults aged 18–65, including people with HIV, SUD, both, or neither. Participants will complete smell tests and computer tasks over two visits, an…
Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can Real-World data match trial results for pembrolizumab in Triple-Negative breast cancer?
Knowledge-focused Not yet recruitingResearchers in Korea are reviewing medical records from about 2,000 patients with triple-negative breast cancer who received pembrolizumab plus chemotherapy before surgery. The study measures how many patients had no detectable cancer left in their breast and lymph nodes at surge…
Sponsor: Yeon Hee Park • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Arkansas study tracks Moms' diets to boost baby health
Knowledge-focused Not yet recruitingThis study follows 125 pregnant women from 30 weeks of pregnancy through their baby's first year. Researchers want to learn how diet, food access, and other social factors affect mothers' health, breastfeeding success, and baby growth. Participants will complete remote visits and…
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Breakfast showdown: High-Fat vs. High-Carb – which worsens blood fats?
Knowledge-focused Not yet recruitingThis study looks at how eating a high-fat or high-carb breakfast changes fat levels in the blood over 8 hours. Researchers will compare results among people with conditions like diabetes, fatty liver, or kidney disease, as well as healthy volunteers. Participants will have two ov…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Super-Resolution heart scans: sharper images without extra radiation?
Knowledge-focused Not yet recruitingThis study will take standard heart CT scans from 1000 adults with structural heart disease and use a super-computer to create ultra-high-resolution images. The goal is to see if these enhanced images show more detail than the originals. No new treatments are being tested; it's a…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can immune aging blood tests predict which older IBD patients thrive on advanced therapies?
Knowledge-focused Not yet recruitingResearchers are observing 300 adults aged 60 and older with inflammatory bowel disease who are starting an advanced therapy chosen by their usual care team. The study tracks immune-aging markers such as CD4/CD8 ratio and IL-6, along with frailty and nutrition, over 52 weeks. The …
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can naming your feelings predict back pain relief?
Knowledge-focused Not yet recruitingResearchers at Marmara University are studying why some people with chronic low back pain and nerve-related leg pain respond better than others to a standard steroid injection near the spine. The team follows 60 adults who are already scheduled for this routine procedure. Before …
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Massive 30-Year study aims to unlock secrets of diabetes and obesity
Knowledge-focused Not yet recruitingThis study will follow 1,000 people aged 8 to 65 who are overweight, have high blood sugar, or have metabolic issues. Researchers will collect blood, saliva, urine, and stool samples during routine clinic visits, along with questionnaires about diet, sleep, and mood. The goal is …
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Fatty meals may trap vitamin e in the blood, study suggests
Knowledge-focused Not yet recruitingThis study investigates how eating three high-fat meals in a row changes vitamin E levels in the blood. Researchers will compare people with normal blood fats to those with high blood fats (hyperlipidemia). The goal is to understand whether fats in the blood can trap vitamin E, p…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New brain zapping technique tested for safety in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests a new form of transcranial magnetic stimulation (TMS) called high-density theta burst stimulation (hdTBS) in 35 healthy adults aged 22 to 60. The goal is to check if hdTBS is safe and to compare its effects on the brain to standard TMS. Participants w…
Phase 1 • Sponsor: National Institute on Drug Abuse (NIDA) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can a questionnaire reveal how many mothers carry trauma from childbirth?
Knowledge-focused Not yet recruitingResearchers at Emile Muller Hospital in Mulhouse, France, want to estimate how many mothers develop post-traumatic stress disorder after giving birth. About 1,000 women who deliver at the hospital are asked to fill out the City Birth Trauma Scale and a short survey about their he…
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Your phone might notice Alzheimer's decline before you do
Knowledge-focused Not yet recruitingResearchers at Poitiers University Hospital are studying whether changes in how people with Alzheimer's use their smartphones track with changes in their ability to handle daily tasks. About 100 participants aged 60 and older will have their Android phone usage and battery data c…
Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Childhood obesity and early puberty: a new study seeks answers
Knowledge-focused Not yet recruitingThis study follows 400 children aged 5 to 7 with obesity or normal weight until age 12. Researchers will track puberty signs, hormones, genes, diet, and chemical exposures to see what predicts early puberty. No treatments are given; the goal is to gather information.
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Do GLP-1 Weight-Loss drugs change how teens eat and feel?
Knowledge-focused Not yet recruitingResearchers at the University of California, San Francisco are following 100 adolescents and young adults, ages 12 to 21, who are starting GLP-1 weight-loss drugs like Ozempic, Wegovy, or Mounjaro. Over one year, participants answer online surveys about their eating behaviors and…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
30 patients to test if nutrition tracking boosts wound healing
Knowledge-focused Not yet recruitingThis pilot study will check if it's possible to collect useful nutrition and health information from 30 adults with diabetic foot ulcers. Researchers want to see if they can recruit enough people and gather complete data. The goal is to learn about patients' diet, body compositio…
Sponsor: Hvidovre University Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Walking memory tests may reveal early Parkinson's clues
Knowledge-focused Not yet recruitingResearchers are studying whether navigational memory fades before other spatial memory in people with Parkinson's disease and related conditions. The pilot includes 80 participants: those with mild or advanced Parkinson's, those with parkinsonism, and healthy volunteers. Particip…
Sponsor: IRCCS San Raffaele Roma • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
French study to reveal who really benefits from obesity drug semaglutide
Knowledge-focused Not yet recruitingThis study will follow 3,000 French patients with severe or complicated obesity who are taking semaglutide (Wegovy) as part of an early access program. Researchers will track weight changes, treatment patterns, and well-being over time using questionnaires. The goal is to underst…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Timing of kidney dialysis in ICU: could earlier start save days?
Knowledge-focused Not yet recruitingThis study looks at over 500,000 critically ill adults in Swedish ICUs to see if starting continuous kidney dialysis (CRRT) earlier affects how long they stay in the ICU. About 5% of these patients receive CRRT. Researchers will compare early versus late initiation of dialysis an…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Fitbit study aims to decode recovery after breast reconstruction
Knowledge-focused Not yet recruitingThis study will give 50 women a Fitbit Inspire 3 to wear before and after DIEP flap breast reconstruction surgery. Researchers will track steps, heart rate, and sleep, and compare that data with short questionnaires about recovery. The goal is to learn more about how patients rec…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Two autoimmune conditions, one child: study probes hidden thyroid trouble
Knowledge-focused Not yet recruitingAutoimmune hepatitis makes a child's immune system attack their liver. Researchers at Assiut University Children's Hospital want to know how many children with this liver condition also develop thyroid disorders such as Hashimoto thyroiditis or Graves' disease. The team will test…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New survey aims to better understand ovarian cancer Patients' daily lives
Knowledge-focused Not yet recruitingThis study is testing a new questionnaire (called the QLQ-OV39) to see how well it measures quality of life in people with ovarian cancer. About 50 adults with early or advanced ovarian cancer will fill out the questionnaire and give feedback. The goal is to make sure the questio…
Sponsor: Helios University Hospital Wuppertal • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists launch deep dive into IBD to uncover hidden clues
Knowledge-focused Not yet recruitingThis study will follow 100 adults with Crohn's disease, ulcerative colitis, or other IBD, plus their healthy relatives, for up to 3 years. Researchers will collect blood, stool, tissue samples, and imaging to track how immune cells and genetics change over time. The goal is to fi…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New biorepository aims to unlock secrets of pulmonary hypertension
Knowledge-focused Not yet recruitingThis study is creating a large collection of blood samples and medical information from 1000 adults with or suspected of having pulmonary hypertension (PH). Researchers hope this resource will help them find new ways to diagnose and treat PH. Participants will provide a blood sam…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Which contact method best warns families of hidden cholesterol danger?
Knowledge-focused Not yet recruitingThis study compares two approaches to notify relatives of people diagnosed with familial hypercholesterolemia (FH), a genetic condition causing very high cholesterol. One method lets patients share information themselves; the other has the study team contact relatives directly. R…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Refugee sleep secrets: study seeks answers
Knowledge-focused Not yet recruitingThis study looks at how stress from being a refugee—like trauma, discrimination, and adjusting to a new culture—affects sleep in Bhutanese refugees living in Ohio. Researchers will hold focus groups and interviews with 70 adults to understand their sleep problems and coping strat…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Your childhood may be driving your food choices: new study investigates
Knowledge-focused Not yet recruitingThis natural history study looks at how life events during childhood might affect eating behaviors and weight gain in adults. Researchers will observe 110 healthy volunteers aged 18 to 60, measuring food intake, physical activity, blood sugar, and body fat. Participants will also…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
China builds national watchdog for brain blood vessel devices
Knowledge-focused Not yet recruitingResearchers at Changhai Hospital are setting up a nationwide system to monitor how well devices and procedures for cerebrovascular conditions perform after they reach the market. The study plans to enroll about 2,000 adults with acute ischemic stroke, narrowed brain or neck arter…
Sponsor: Changhai Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists launch 5-year watch on rare genetic Parkinson's to unlock disease secrets
Knowledge-focused Not yet recruitingThis study follows 70 people with PRKN- or PINK1-linked Parkinson's disease, as well as those with typical Parkinson's and healthy volunteers, over 5 years. Researchers will track movement, thinking, and mood symptoms, and collect blood, urine, and optional spinal fluid or muscle…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Can a migraine pill sway the Body's balance reflex?
Knowledge-focused Not yet recruitingResearchers want to know whether CGRP, a protein involved in migraine, also affects the vestibulo-ocular reflex, the automatic eye movement that keeps vision steady when the head turns. The trial gives 80 people at the University Hospital Zurich either a single dose of atogepant,…
Phase 4 • Sponsor: Konrad Peter Weber • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a smartwatch help cancer patients during chemo and radiation?
Knowledge-focused Not yet recruitingThis study will test whether cancer patients receiving chemotherapy and radiation therapy can use wearable health devices, like fitness trackers, to monitor their heart rate and activity levels. Twenty adults will wear the device during treatment and for four weeks after, uploadi…
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can regional data improve bone marrow transplant results for blood cancers?
Knowledge-focused Not yet recruitingResearchers at Assiut University are studying adults with blood cancers who receive an autologous hematopoietic stem cell transplant, a procedure that uses a patient's own stem cells. The study follows 123 participants to measure survival, progression-free survival, complications…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study to define healthy blood clotting ranges for kids
Knowledge-focused Not yet recruitingThis study will measure normal blood clotting values in 240 children under 18 who are having surgery or a procedure with anesthesia. The goal is to establish reference ranges for the Quantra system, a device that checks how well blood clots. This information will help doctors bet…
Sponsor: HemoSonics LLC • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Migraines and tension headaches may be hidden companions to multiple sclerosis
Knowledge-focused Not yet recruitingResearchers at Assiut University Hospitals are studying how often adults with multiple sclerosis also get primary headaches such as migraine and tension-type headache. About 100 patients will complete a single visit that includes a neurological exam, headache history, disability …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
The hidden handshake that decides whether an embryo implants
Knowledge-focused Not yet recruitingResearchers want to understand why most IVF embryo transfers fail to implant and what goes wrong in pregnancies complicated by preeclampsia. They will collect small tissue samples from the womb lining of up to 500 women aged 18 to 50 who are already scheduled for a diagnostic hys…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists to examine liver tissue after gene therapy for hemophilia
Knowledge-focused Not yet recruitingThis observational study will take small liver samples from 8 adults with hemophilia A or B who had gene therapy at least 6 months ago. Researchers want to see how the gene therapy affected liver cells, including how many cells still carry the therapy and whether there is any liv…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Cheap blood count ratios eyed as window into Myeloma's inflammatory grip
Knowledge-focused Not yet recruitingMultiple myeloma is a blood cancer in which abnormal plasma cells build up in bone marrow, and inflammation may shape how the disease behaves. Researchers at Assiut University plan to study 60 people newly diagnosed with myeloma before any anti-myeloma treatment begins. They will…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can gene therapy zolgensma safely improve motor skills in SMA?
Knowledge-focused Not yet recruitingThis study follows 80 people with spinal muscular atrophy (SMA) in Japan who receive Zolgensma (onasemnogene abeparvovec) as an intrathecal injection. The goal is to track safety issues, such as liver problems or blood clotting abnormalities, and to measure changes in motor funct…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can exercise shield the eyes of glaucoma patients?
Knowledge-focused Not yet recruitingResearchers at Shanghai General Hospital are studying whether exercise relates to visual function in people with glaucoma. About 100 patients aged 18 to 100 answer a questionnaire about their physical activity. The team then measures central visual field, retinal nerve fiber laye…
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Brain waves may reveal which children recover from encephalopathy
Knowledge-focused Not yet recruitingResearchers at Assiut University Children Hospital are studying whether abnormal brain-wave patterns on an EEG can predict how well children with encephalopathy recover. The study follows 147 children aged 1 month to 18 years who have altered consciousness from encephalopathy. Ea…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can Real-World data reveal the best rectal cancer treatment?
Knowledge-focused Not yet recruitingThis observational study gathers information from routine care on how localized rectal cancer is treated across Austrian hospitals. It aims to document the variety of treatment approaches, including total neoadjuvant therapy and immunotherapy, and their outcomes. By analyzing thi…
Sponsor: Austrian Breast & Colorectal Cancer Study Group • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Your smartwatch could predict blood sugar crashes before they happen
Knowledge-focused Not yet recruitingThis study will test whether combining continuous glucose monitor (CGM) data with information from a smartwatch and a phone app (like meals and activity) can better predict blood sugar levels in people with type 2 diabetes. Thirty-six adults will wear a CGM and smartwatch and log…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Could we ditch antibiotics after a burst appendix? new study investigates
Knowledge-focused Not yet recruitingThis pilot study looks at whether it is safe to stop giving antibiotics after surgery for a burst (perforated) appendix. About 100 adults will be randomly assigned to receive either antibiotics or no antibiotics after their operation. The main goal is to see if a larger study is …
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Triple-Pronged attack on gut inflammation put to the test
Knowledge-focused Not yet recruitingResearchers are testing whether blocking three inflammation pathways at once (TL1A, IL-23, and α4β7) calms inflamed intestinal tissue more effectively than blocking each pathway alone. The study enrolls 30 people: 10 with ulcerative colitis, 10 with Crohn's disease, and 10 withou…
Sponsor: PhoenixLAB srls • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
The clotting test that could reshape warfarin care in egypt
Knowledge-focused Not yet recruitingPeople with rheumatic heart disease and atrial fibrillation take warfarin to prevent strokes, but the drug only works safely when blood clotting stays in a narrow target range. Researchers at Assiut University are studying about 90 Egyptian adults on warfarin for at least six mon…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
AI nutrition coach for Moms-to-Be: a new study tests a Chatbot's helpfulness
Knowledge-focused Not yet recruitingThis study will test if an AI chatbot can give helpful nutrition advice to pregnant women. About 100 women will either use the chatbot or get standard care. The goal is to see if the chatbot is easy to use and if it helps improve diet and knowledge about conditions like gestation…
Sponsor: Hong Kong Metropolitan University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study tracks hidden dangers of common leukemia drug
Knowledge-focused Not yet recruitingThis study will follow 200 children with acute lymphoblastic leukemia or lymphoma to learn more about the short- and long-term side effects of asparaginase drugs. Researchers will track how often serious toxicities occur during standard treatment and a newer therapy called SJALL2…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Inside the metabolic chamber: scientists probe extreme obesity
Knowledge-focused Not yet recruitingThis study will measure how the body uses energy and burns fat in 10 people with extreme obesity (BMI of 60 or higher). Participants will spend 23 hours in a special metabolic chamber and drink a labeled water to track energy use over a week. The goal is to better understand meta…
Sponsor: Pennington Biomedical Research Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can modern heart failure drugs reverse damage in three months?
Knowledge-focused Not yet recruitingResearchers at Assiut University Hospitals are following 250 adults with chronic heart failure and reduced ejection fraction who are on or starting guideline-directed medical therapy. Over three months, the team measures changes in heart pumping function, kidney filtration, quali…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a simple questionnaire improve sleep apnea treatment?
Knowledge-focused Not yet recruitingThis study tests whether a new questionnaire called PLATO can help dentists track how well oral appliance therapy works for people with obstructive sleep apnea. The questionnaire, developed by the American Academy of Sleep Medicine, measures patient-reported outcomes. Researchers…
Sponsor: Nevada Dental Sleep • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
The 20-Minute squeeze: how eye injections push pressure up
Knowledge-focused Not yet recruitingAnti-VEGF injections treat conditions like diabetic macular edema, age-related macular degeneration, and retinal vein occlusion by adding fluid inside the eye, which can briefly raise eye pressure. This observational study at Assiut University follows 50 adults receiving these ro…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
New study aims to slash cervical cancer deaths in HIV-positive women
Knowledge-focused Not yet recruitingThis study tests better ways to screen and treat cervical cancer in women living with HIV in Kenya, who face a much higher risk. Researchers will use HPV self-testing, care navigators, and a mobile app to help more women get diagnosed and treated. The goal is to find strategies t…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Do social factors decide who completes lymphoma treatment?
Knowledge-focused Not yet recruitingResearchers are examining health records from adults diagnosed with diffuse large B-cell lymphoma, a fast-growing blood cancer, across multiple UK hospitals. The study asks whether a patient's ethnicity, level of socioeconomic deprivation, and other health conditions influence ho…
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a video chat keep dementia care true to Patients' wishes?
Knowledge-focused Not yet recruitingResearchers at Tufts Medical Center are testing an advance care planning program for people 65 and older who have Alzheimer's disease or related dementias, or who face a higher risk of dying within a year. The program pairs participants with counselors and videos that explain car…
Sponsor: Tufts Medical Center • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Fewer dialysis sessions: can Twice-Weekly work as well?
Knowledge-focused Not yet recruitingResearchers at Assiut University Hospitals compare adults with kidney failure who receive hemodialysis twice a week versus three times a week. The study tracks health-related quality of life, dialysis adequacy, urine output, and hospitalizations over time. About 130 participants …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Does your morning coffee stir up heart rhythm trouble?
Knowledge-focused Not yet recruitingResearchers want to know whether caffeine consumption is linked to irregular heartbeats and daily physical activity in adults with heart failure, reduced left ventricular ejection fraction, and an implantable cardioverter-defibrillator (ICD). About 170 participants fill out a one…
Sponsor: Jean-Benoît Le Polain de Waroux • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Why do some children arrive at the ER with a racing or skipping heart?
Knowledge-focused Not yet recruitingResearchers at Assiut University Children Hospital are studying how often children who come to the emergency department have an abnormal heart rhythm. The study includes children aged 1 month to 18 years who arrive with symptoms such as palpitations, chest pain, fainting, or trou…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Scientists launch Largest-Ever study to unravel Cystinosis's Long-Term effects
Knowledge-focused Not yet recruitingThis study follows 250 people with cystinosis, a rare genetic disorder that causes a buildup of the amino acid cystine, leading to damage in the kidneys, eyes, and other organs. Researchers will track how the disease progresses over time, including kidney function, eye problems, …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can better aerobic fitness help MS patients keep their balance?
Knowledge-focused Not yet recruitingResearchers are studying whether aerobic fitness relates to walking, balance, and fatigue in people with multiple sclerosis. About 70 adults with relapsing-remitting or progressive MS will take walking tests and balance challenges that involve soft surfaces and head movements. Th…
Sponsor: Suleyman Demirel University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a DASH diet change your gut bugs and help you lose weight?
Knowledge-focused Not yet recruitingThis study will give 28 women with obesity either a calorie-restricted DASH diet or a standard American diet for 4 weeks. Researchers will track weight changes and analyze stool samples to see how diet affects gut bacteria and related health markers. The goal is to understand how…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can we end stigma in cancer care? a new study investigates
Knowledge-focused Not yet recruitingThis study asks whether healthcare providers in cancer centers hold negative attitudes toward patients with mental disorders, and what factors influence those views. Researchers will survey about 1,000 oncology professionals using a stigma questionnaire and interview some of them…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Why do some preterm babies need breathing machines longer?
Knowledge-focused Not yet recruitingResearchers at Assiut University Children Hospital are tracking 100 preterm infants who need invasive mechanical ventilation in the neonatal intensive care unit. The study aims to identify which early factors predict prolonged ventilation, defined as more than 7 days or frequent …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New MRI technique aims to spot kidney transplant rejection early
Knowledge-focused Not yet recruitingThis study will use advanced MRI scans to look at kidney transplants in 140 patients. The goal is to see if MRI can measure how well the kidney is working and tell the difference between stable function and problems like rejection. Researchers hope this could lead to a non-invasi…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Rare ebola cousin under the microscope as doctors chart its deadly course
Knowledge-focused Not yet recruitingFiloviruses such as Ebola and Marburg cause severe hemorrhagic fevers with high death rates, and doctors know little about rare types like Bundibugyo virus. This observational study follows patients in France with confirmed filovirus disease to record how the illness unfolds. Res…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Mapping how thyroid tumors spread and what surgery leaves behind
Knowledge-focused Not yet recruitingResearchers at Sohag University Hospitals are reviewing the medical records of 30 people treated for papillary thyroid cancer, the most common type of thyroid cancer. The study examines how far tumors extended beyond the thyroid gland and which complications appeared soon after s…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a tiny doppler turn blood flow sounds into pictures to save rebuilt tissue?
Knowledge-focused Not yet recruitingResearchers at Mayo Clinic are studying whether an implantable Doppler monitor can record the sound of blood flowing through a free flap and convert it into a visual signal. The trial enrolls 100 adults scheduled for free flap surgery, a procedure that moves tissue to rebuild par…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a simple ultrasound tell surgeons where tumor ends and healthy brain begins?
Knowledge-focused Not yet recruitingThis Mayo Clinic study will test whether a special ultrasound technique, called shear wave elastography, can measure how stiff brain tumors are compared to healthy brain tissue during surgery. Researchers will enroll 30 adults with newly diagnosed or recurrent brain tumors. The g…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a phone app help end HIV stigma? south africa trial tests U=U education
Knowledge-focused Not yet recruitingThis study tests whether a video app that explains 'Undetectable = Untransmittable' (U=U) can help people with HIV stay on treatment and keep the virus under control. About 880 people from clinics in South Africa will use the app during counseling. The goal is to see if better un…
Sponsor: Boston University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New study aims to uncover hidden danger in stem cell transplants
Knowledge-focused Not yet recruitingThis study will follow 85 adults receiving stem cell transplants to track a serious but often missed complication called TA-TMA. Researchers want to find out how common it is and how it affects survival. Participants will provide blood samples and have standard follow-up care.
Sponsor: Manuel Ricardo Espinoza-Gutarra • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Pollution and pain: study probes link between chemicals and endometriosis severity
Knowledge-focused Not yet recruitingThis study will investigate whether exposure to persistent organic pollutants (POPs) like dioxins and PCBs is linked to more severe endometriosis. Researchers will analyze blood samples from 650 women with endometriosis living in the Ile-de-France region of France. The goal is to…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Canadian study aims to unlock secrets of cancer immunotherapy
Knowledge-focused Not yet recruitingThis study collects tumor tissue and blood samples from 120 cancer patients who are receiving or will receive immunotherapy. The samples will be stored in a biobank for future research to better understand how these treatments work. No direct treatment is given; the goal is to ga…
Sponsor: Canadian Cancer Trials Group • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
A routine blood count may reveal how severe diabetic ketoacidosis will be
Knowledge-focused Not yet recruitingResearchers at Assiut University Hospitals are studying whether a simple calculation from two routine blood tests, the leukocyte glucose index, relates to how severe diabetic ketoacidosis becomes in adults with diabetes. The index multiplies white blood cell count by blood sugar …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Brain scans and biosamples: mapping why OCD looks so different in every person
Knowledge-focused Not yet recruitingResearchers at Shanghai Mental Health Center are following 500 people with obsessive-compulsive disorder to see how symptoms, daily functioning, and treatment responses change over time. The study includes adults aged 18 to 60, including some who have never received OCD treatment…
Sponsor: Shanghai Mental Health Center • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can teaching pain science rewire how older adults think about knee arthritis?
Knowledge-focused Not yet recruitingMany older adults with knee osteoarthritis believe their pain comes mainly from joint wear and tear, which can lead to fear of movement and less activity. Researchers at McMaster University are comparing two web-based education programs: one that explains pain as a mix of biologi…
Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a web platform teach students to make better dementia care decisions?
Knowledge-focused Not yet recruitingResearchers at Chang Gung Memorial Hospital are studying whether an interactive web-based training platform improves how gerontology students handle dementia care decisions. The study first interviews second-year students about the challenges they face when caring for people with…
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Hidden spinal cord changes may lurk in common neck pain
Knowledge-focused Not yet recruitingResearchers at a Turkish hospital are observing 400 adults who visit a pain clinic with cervical radicular pain, the shooting or aching arm pain that comes from a pinched nerve root in the neck. Participants receive routine neurological exams, including the Hoffmann sign, and cer…
Sponsor: Ankara City Hospital Bilkent • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a video keep thyroid cancer patients on track after surgery?
Knowledge-focused Not yet recruitingAfter thyroid surgery for differentiated thyroid cancer, patients often need to take thyroid hormone at doses that keep TSH in a specific target range. Researchers at West China Hospital are testing whether adding a short educational video to standard instructions helps patients …
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Personalized antibiotic dosing could save lives in the ICU
Knowledge-focused Not yet recruitingThis study aims to find the best way to dose the antibiotic ceftazidime for patients in intensive care with serious infections. Many ICU patients don't get enough of the drug because their bodies process it differently. The researchers will test a personalized dosing plan to keep…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Finger-Prick blood tests could let lung cancer patients skip clinic visits
Knowledge-focused Not yet recruitingResearchers are testing whether people with non-small cell lung cancer can collect their own small blood samples at home using a finger-prick kit. Participants receive standard treatment with docetaxel, paclitaxel, alectinib, or lorlatinib, and the samples measure how much cancer…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Is thicker blood a hidden player in ARDS?
Knowledge-focused Not yet recruitingARDS is a severe lung condition that damages the tiny air sacs and blood vessels in the lungs, leading to low oxygen and unstable circulation. Researchers at Hospices Civils de Lyon are measuring blood viscosity, or how thick and resistant to flow the blood is, in ICU patients wi…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Hong kong launches study to track heart shock survival
Knowledge-focused Not yet recruitingThis study will track 320 people in Hong Kong who have a heart attack complicated by cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. Researchers will collect data on standard treatments, including the use of a heart pump called Impella, to…
Sponsor: Prince of Wales Hospital, Shatin, Hong Kong • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can brain stimulation rewire how depressed patients learn from rewards?
Knowledge-focused Not yet recruitingResearchers are studying how four types of brain stimulation for depression, ECT, TMS, VNS, and taVNS, affect decision-making and reward learning over time. About 100 patients receiving these treatments at a German hospital complete repeated online tasks that measure how they lea…
Sponsor: Dr. Nils B. Kroemer • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can AI help pregnant patients take charge of their hospital care?
Knowledge-focused Not yet recruitingResearchers at Sheba Medical Center are testing whether AI-generated medical summaries help pregnant patients hospitalized for high-risk pregnancies feel more informed and involved in their care. Half of the 200 participants receive up to three AI-written summaries of their medic…
Sponsor: Sheba Medical Center • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Why does esophageal cancer come back after treatment? researchers search medical records for clues
Knowledge-focused Not yet recruitingResearchers are reviewing medical records of 100 people with esophageal squamous cell carcinoma who received immunotherapy plus chemotherapy before surgery to remove the cancer. The study examines when and where cancer returns and which patient traits, treatment details, scan res…
Sponsor: Peking University Cancer Hospital & Institute • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Brain scans reveal why fatty foods repel anorexia patients
Knowledge-focused Not yet recruitingThis study looks at how the brains of women with anorexia nervosa respond to fatty food smells and images. Researchers will use brain scans to compare their reactions to those of healthy women. The goal is to understand why fatty foods cause aversion, which could help improve fut…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can exercise and Self-Control shield kids from binge eating?
Knowledge-focused Not yet recruitingResearchers at the University of Texas at Dallas are studying how physical activity, sedentary behavior and self-control relate to loss of control eating in children. The study follows 200 children aged 10 to 12 for three years, using brain scans, activity monitors, and real-time…
Sponsor: The University of Texas at Dallas • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can a smartphone app improve medication adherence in schizophrenia?
Knowledge-focused Not yet recruitingThis study will test a new mobile mental health app designed to help people with schizophrenia or schizoaffective disorder stick to their medication routine. Researchers will enroll 50 adults who are in remission and see if using the app is practical and well-liked. The goal is t…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can sleep, neck pain, and fatigue explain Migraine's daily toll?
Knowledge-focused Not yet recruitingResearchers at Lokman Hekim University are studying how migraine affects daily life and which factors track with worse disability. About 100 adults diagnosed with primary migraine complete questionnaires on headache features, sleep quality, fatigue, neck pain, and lifestyle, plus…
Sponsor: Lokman Hekim University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Jardiance under the microscope: new study tracks heart failure outcomes in china
Knowledge-focused Not yet recruitingThis study will observe 3,000 adults in China with a type of heart failure called HFpEF who are starting the drug Jardiance. Researchers will track how many patients are hospitalized for heart failure or die from heart-related causes over time. The goal is to see how effective an…
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC